Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Protocols, grant proposals, registered reports (RR1)

Latest Submissions Open for Peer Review

Open peer-review allows users to assign themselves as peer-reviewers. Reviews are expected to be submitted within 2 weeks. Submitting authors have to opt-in to have their submissions openly peer-reviewed (recommended).

Titles/Abstracts of Articles Currently Open for Review:

  • Background: : Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine-metabolic disorder driven by a complex interplay of hyperandrogenism, insulin resistance, and chronic low-grade inflammation. While Metformin addresses systemic insulin sensitivity, it leaves the upstream trigger of gut dysbiosis and mucosal endotoxemia unmanaged. This study introduces a distinct therapeutic paradigm by combining Metformin with a strain-specific formulation of Lactobacillus crispatus to target the gut-metabolic axis directly. Unlike generic probiotic blends, L. crispatus actively mitigates gastrointestinal inflammation through specialized Surface Layer Proteins (SLPs) that physically reinforce the epithelial barrier against lipopolysaccharide (LPS) translocation, alongside strain-derived hydrogen peroxide production that upregulates host mucosal PPAR- γ to block NF-kB driven cytokine transcription ( TNF-α and IL-6). By dampening this localized inflammatory cascade, this metabolic-inflammatory regimen aims to protect IRS-1 signaling, alleviate hyperinsulinemia, to restore normal ovarian steroidogenesis. Objective: Primary Objective The PCOME Study is to compare the change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) from baseline to 3 months across the three intervention groups—Probiotic, Metformin, and Combination therapy—in women diagnosed with PCOS. Secondary Objectives The PCOME Study aims to evaluate the impact of the three intervention regimens (Probiotic, Metformin, and Combination therapy) on the following parameters at 3 months: 1. Inflammatory and Gut Health Markers • Serum and fecal calprotectin levels • Serum acylated ghrelin (AGH) levels • Fecal short-chain fatty acid (SCFA) concentrations • Serum zonulin levels (as a marker of intestinal permeability) 2. Gut Microbiome Profile • Alpha diversity (e.g., richness and evenness) • Beta diversity (community structure) • Differential abundance of key bacterial taxa, including Lactobacillus, Bifidobacterium, Akkermansia muciniphila, and the Bacteroidetes/Firmicutes ratio 3. Metabolic and Hormonal Markers • Additional markers of insulin resistance: fasting glucose, fasting insulin, and glycated hemoglobin (HbA1c). • Markers of hyperandrogenism: total testosterone, free androgen index (FAI), and sex hormone-binding globulin (SHBG) 4. Clinical and Anthropometric Outcomes • Body mass index (BMI) and waist-hip ratio (WHR) • Assessment of hirsutism using the modified Ferriman-Gallwey score • Menstrual regularity Methods: This open-label, randomized, hospital-based trial at AIIMS Bhubaneswar will assess the effects of probiotic and/or metformin therapy in women aged 18–40 years diagnosed with PCOS per Rotterdam criteria. A total of 138 participants will be randomized equally into three groups: probiotics only, metformin only, and combination therapy. The 3-month intervention includes metformin (1000 mg/day) and a specified Lactobacillus crispatus containing probiotic (2 capsules/day). The primary outcome is the change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR). Key secondary outcomes include changes in serum/fecal calprotectin, AGH, total testosterone, and fecal microbiome profile. Results: Not ready yet Conclusions: This trial will provide critical, mechanistic evidence on whether the targeted, strain-specific action of L. crispatus can work synergistically with Metformin to heal the intestinal mucosal barrier, arrest systemic endotoxemia, and rescue disrupted gut-brain-endocrine signaling. By validating this novel metabolic-inflammatory regimen against localized (calprotectin) and systemic (AGH, HOMA-IR) endpoints, this study intends to establish a highly integrated, microbiome-targeted therapeutic strategy capable of optimizing long-term metabolic and reproductive health outcomes in women with PCOS. Clinical Trial: CTRI/2025/09/094113

  • Background: Behavioral interventions are more effective when co-designed with people who have lived and living experience (PWLLE) of the target issue. However, traditional co-design processes position participants as idea generators whose concepts must be translated into functional tools by professional developers, creating a gap between participant vision and final product. The emergence of vibe coding—a practice in which users describe desired software functionality in natural language and artificial intelligence (AI) generates the corresponding code—presents a novel opportunity to close this gap by enabling participants to build their own intervention tools directly. Objective: This paper proposes a methodological framework for integrating vibe coding into the co-design of behavioral interventions, whereby PWLLE are guided by researchers to brainstorm, prototype, and iteratively build digital tools that address their self-identified needs. Methods: We synthesized literature from participatory design, behavioral science, experience-based co-design (EBCD), and AI-assisted software development to construct a 5-phase protocol: (1) Contextual Grounding, (2) Participatory Ideation, (3) Vibe Coding Workshops, (4) Iterative Refinement, and (5) Evaluation and Reflection. Each phase is described in detail with procedural guidance, ethical considerations, and worked examples. We identify key facilitators (researcher scaffolding, prompt literacy training, structured AI interaction protocols) and barriers (technical limitations of AI-generated code, digital literacy disparities, quality assurance requirements) to implementation. Results: Preliminary pilot vibe coding activities were conducted through SmokeFreeConnect (SFC), a community-based smoking cessation program designed to enhance social connection and peer support for individuals attempting to quit combustible cigarette smoking. One pilot session led to the collaborative conceptualization of SmokeFreeQuest, a prototype smoking cessation application, with positive feedback received regarding the development process and prototype concept. As of May 2026, formal participant recruitment and enrollment for the proposed focus groups had not yet commenced. Additional vibe coding sessions are planned for Summer 2026, with initial findings expected in January 2027. Conclusions: Vibe coding offers a transformative extension to participatory co-design methodologies in behavioral science. By enabling PWLLE to directly build the tools they need, this approach strengthens participation beyond consultation, aligns with self-determination theory (SDT), and generates interventions that are more contextually responsive. Future research should include feasibility trials, effectiveness evaluations, and the development of ethical guidelines for AI-mediated participatory research. Clinical Trial: N/A

  • Beyond the Clinic: Protocol for Enhancing Depression Surveillance with a Digital Biomarker

    Date Submitted: May 21, 2026
    Open Peer Review Period: May 21, 2026 - Jul 16, 2026

    Background: Major depressive disorder (MDD) is characterized by persistent depressed mood, loss of interest, recurrent thoughts of death, and significant physical and cognitive symptoms. Despite effective treatment, up to one-third of patients relapse within months after discharge from depression care, revealing a critical gap in post-discharge surveillance, especially in rural areas with limited access to care and follow-up engagement. The Collaborative Care Model (CoCM), a widely adopted framework for managing depression in primary care, has improved detection and treatment outcomes; however, monitoring symptom recurrence after patients leave structured care still remains challenging. Digital technologies, especially smartphones, offer a promising way to close this gap by capturing passive behavioral and physiological data, including psychomotor activity, sleep, movement, social interaction, and light exposure. Building on prior work showing that passively sensed data can capture depression severity, mood fluctuations, and antidepressant use, we propose developing a clinically integrated digital biomarker to predict depression recurrence. Objective: (1) Test whether patterns in smartphone sensor features predict next-month recurrence of depressive symptoms in post-discharge CoCM patients with an AUC ≥ 0.8; and (2) to evaluate whether Electronic Health Record (EHR) integration of a passive sensing–based prediction model is associated with reduced MDD recurrence over six months compared to usual care. Methods: First, we will recruit up to 120 patients who have been enrolled within the Collaborative Care model to install the HIPAA-compliant MoodTriggers app on their personal smartphones to passively collect multimodal sensor data and complete monthly PHQ-9 assessments for six months. ConvLSTM models will predict next-month PHQ-9 scores, and Shapley values will identify influential features. Acceptability will be assessed through participation metrics and interviews. Second, a randomized trial of up to 200 patients will test effectiveness by evaluating whether EHR-integrated alerts based on the digital biomarker reduce depressive symptom recurrence over six months following CoCM discharge. Results: Funded 2025–2029, this project aims to create a scalable, clinically embedded digital biomarker for post-discharge depression care. Conclusions: N/A Clinical Trial: The study procedures have been registered on clinicaltrials.gov at NCT07174557.

  • Background: Transition to practice can be challenging for new-to-practice nurse practitioners (NPs) and physician assistants/associates (PAs). Internationally, there has been an increase in the number of postgraduate training programs across health care settings. A scoping review found that outcomes were reported in 60% of 216 articles. However, there is no evaluation and synthesis of associated program outcomes. Objective: By building upon earlier work, the purpose of this systematic review is to assess the evidence quality of the literature specifically reporting on program-level outcomes for NP and PA postgraduate training programs. We will appraise the rigor of outcomes measurement, analysis, and reporting. Methods: This review will follow the JBI approach for systematic reviews. MEDLINE (PubMed), CINAHL (EBSCOhost), Cochrane Library (Wiley) Cochrane Central Register of Controlled Trials, Social Science Database (ProQuest), and Health Source: Nursing/Academic Edition will be searched for articles published in peer-reviewed journals since 1990 and in English. Studies on NP and PA postgraduate training programs (residencies, fellowships, onboarding) reporting program-level outcomes (job placement, turnover and retention, productivity, and costs of programs) will be included. Studies using quantitative and mixed-methods study designs will be included. Conference abstracts, editorials/opinions, dissertations/theses, reviews, and qualitative studies will be excluded. Screening, data extraction, and critical appraisal will be conducted by 2 independent reviewers. Relevant data will be extracted, and the level of rigor of each study will be established using standardized critical appraisal tools. Results: This review began in June 2025, and searches of databases were completed in October 2025. The title and abstract screening stage was completed December 2025. As of May 2026, we have started full text screening. Conclusions: Understanding the quality of outcomes reporting of post-graduate training programs for NPs and PAs will be valuable to researchers, administrators, and clinicians, as findings can inform future program development, implementation, and evaluation. Clinical Trial: PROSPERO 2025 CRD420251091013

  • Population-based cancer screening programmes are designed to enable early detection and timely treatment of selected cancers, with the ultimate aim of reducing morbidity and mortality; yet participation remains critically low in the Campania region of southern Italy. Within the MIRIADE project, previous studies identified psychosocial antecedents of cervical, breast and colorectal cancer screening adherence (attitude, subjective norms, perceived behavioural control, self-identity, anticipated regret, action and coping planning). Based on these variables, a profiling study identified data-driven psychosocial subgroups among citizens eligible for colorectal cancer screening (CRCS; three profiles) and female-only cancer screenings (FOCS; four profiles), and one study developed and validated a framework for multiple reasons for screening participation. Building on these empirical foundations, the present paper describes a protocol for a randomized controlled trial (RCT) comparing the efficacy of targeted and tailored persuasive messaging strategies—and a usual-care control—for promoting screening participation. The T0 baseline assessment was conducted as part of the companion profiling study, during which participants completed psychosocial measures and ranked their personal reasons for screening participation, after which they were profiled via Reduced k-means. At T1, participants are randomly allocated to: (a) a targeted condition, receiving a persuasive message adapted to their profile’s psychosocial characteristics; (b) a tailored condition, receiving a message that additionally integrates the individual’s most personally relevant reason for screening; or (c) a usual-care control. The primary outcome is post-intervention screening intention (T1). A six-month behavioural follow-up (T2) assesses self-reported screening uptake. Message effectiveness and personal relevance are evaluated as process outcomes. Pre-tests with a subsample ensure message adequacy. This protocol provides a theory-grounded, empirically informed framework for experimental comparison of targeted and tailored interventions for both colorectal and female-only cancer screenings. It employs data-driven profiling, integrates individually relevant reason-based content, and is designed for scalability within regional public health infrastructure. Protocol version: Version 1.0, 15/05/2026.

  • Background: Older Chinese American adults with limited English proficiency frequently rely on culturally and linguistically tailored online media platforms for dementia education and health literacy. Existing digital health evaluation frameworks primarily assess the internal quality and accuracy of educational materials while overlooking the recommendation environments through which users encounter health information. Commercial recommendation systems may expose users to medically unverified or commercially motivated health content adjacent to evidence-based dementia education resources. Objective: This protocol establishes a reproducible computational framework for auditing recommendation environments surrounding Cantonese-language dementia education videos on YouTube. The study introduces the concept of algorithmic noise adjacency, defined operationally as the concentration of recommendation nodes whose informational utility diverges from evidence-based dementia education objectives within local recommendation neighborhoods. Methods: The protocol uses an automated socio-technical audit framework centered on 2 Cantonese-language dementia education videos previously examined in longitudinal digital outreach research. A Selenium WebDriver pipeline with a headless Chromium browser architecture and fingerprinting mitigations will simulate 1200 independent browsing sessions distributed uniformly across a 90-day window. Sessions will be routed through rotating residential proxy infrastructure localized to Southern California Chinese American communities. During each session, the top 10 sidebar recommendation videos adjacent to the source clinical asset (the anchor video) will be extracted. Recommendation metadata will undergo structured semantic classification into 5 mutually exclusive categories: (A) verified public health and clinical infrastructure; (B) diaspora culture and entertainment; (C) commercially motivated health content lacking established clinical validation; (D) unverified alternative medicine; and (E) ambiguous or unclassified baseline noise. Double-coding and consensus adjudication of a random 10% sample will be used to establish inter-rater reliability. Generalized linear mixed-effects models (GLMM) with logit link functions, session-level random intercepts, and reciprocal rank slot-position weighting will evaluate recommendation characteristics while accounting for clustering within browsing sessions. Primary outcome measures include the Noise Adjacency Ratio (NAR), slot-weighted NAR, recommendation recurrence density, and neighborhood entropy. Secondary analyses will evaluate temporal recommendation drift and cross-session recommendation variability. Results: Protocol development and pilot automation testing were finalized in May 2026. Automation stress testing, semantic calibration, and proxy validation are scheduled for September 2026. Data collection is projected to occur over a 90-day interval following deployment of the finalized extraction architecture. Conclusions: This protocol proposes a structural informatic auditing framework for minority-language digital health ecosystems. By shifting evaluation from isolated content quality toward surrounding recommendation neighborhoods, the study may provide digital health researchers with a reproducible methodology for characterizing health-information exposure conditions among linguistically isolated populations.

  • Background Occupational stress and burnout are pervasive among nurses, adversely affecting their well-being, job satisfaction, and the quality of patient care. Mindfulness-Based Resilience Training has emerged as a potential intervention to mitigate these challenges. Objective The study proposes to evaluate the effectiveness of an 8-week Mindfulness-Based Resilience Training program on occupational burnout, stress, coping strategies and biophysiological parameters among staff nurses at a tertiary care centre. Methods This randomized controlled trial will recruit registered nursed from a tertiary care centre with more than 1 year of experience. Eligible participants will be randomly assigned to either the intervention group or control group. The Mindfulness-Based Resilience Training comprises of weekly 90-minute sessions over 8 weeks, integrating mindfulness practices, cognitive restructuring and resilience-building techniques. The outcomes include occupational burnout, stress levels, coping strategies and biophysiological parameters. Data will be collected at baseline, immediately post intervention (post-test- 1) and at 12-weeks (post-test-2). Descriptive statistics, independent t-tests, and repeated measures ANOVA will be used to analyse the data. Results The study is currently in the participant recruitment and data collection phase. Baseline assessments have been initiated, and post-intervention evaluations will be conducted as per protocol. The findings are expected to provide evidence on the effectiveness of Mindfulness-Based Resilience Training among staff nurses. Conclusion It is hypothesized that the Mindfulness-Based Resilience Training program will significantly reduce occupational burnout and perceived stress, enhances adaptive coping strategies and improves biophysiological parameters among staff nurses. Results may support the integration of Mindfulness-Based Resilience Training into workplaces as a wellness initiative for nurses. Trail Registration: The study has been registered at Clinical Trials Registry of India (CTRI/2025/03/083718; Registration date: 28/03/2025) Keywords: Burnout, coping skills, nurses, psychological wellbeing, perceived stress scale

  • Background: Fragmented care across sectors inadequately addresses the complex care needs of children with special healthcare needs (SHCN), increasing the risk of adverse health and developmental outcomes and placing a burden on caregivers. Although integrated care may reduce unmet needs and improve care quality, its implementation remains constrained by limited evidence on patient journeys, challenges in care delivery, and the costs associated with care practices. Objective: The Pediatric Integrated Care (PICAR) Study aims to (1) examine patient journeys across care sectors and care integration among children with different special healthcare needs (SHCN), compared to those without SHCN, their correlates, and associations with health-related outcomes, (2) identify challenges in care delivery, (3) quantify direct and indirect costs from healthcare system and family perspectives, and (4) develop recommendations to strengthen integrated care for this population. Methods: This study uses an exploratory sequential mixed-methods design comprising (1) semi-structured interviews, (2) claims data analyses, (3) a prospective cohort study, and (4) health economic analyses. We conduct interviews with children with SHCN, their caregivers, and healthcare professionals across disciplines and sectors. Claims data from a statutory health insurance fund cover children aged 3–15 years over six-years, including those with selected index diagnoses (type 1 diabetes, asthma, disorders of psychological development, behavioral and emotional disorders, cerebral palsy), and children without SHCN. A random subsample is invited to participate in the cohort study. Interviews explore patient journeys, care-related burden, and opportunities to improve care delivery. Claims data capture service utilization and associated costs across sectors. Informed by qualitative findings, cohort surveys assess perceived care provision (e.g., care integration), family-related aspects (e.g., navigational health literacy), and child and caregiver health status. Health economic analyses quantify direct and indirect costs. Interview data are analyzed using qualitative content and thematic analyses. Claims data are examined using state sequence analyses to identify patterns in patient journeys. Cohort data are analyzed using regression models, propensity score matching, and cluster analyses to examine correlates of care integration, associations between care challenges and health outcomes, and subgroups of families with vulnerability profiles. Data integration and development of recommendations occur iteratively. Results: Data collection and analyses of the semi-structured interviews were completed in June 2025, with initial findings published in March 2026. We conducted the first survey of the cohort study between May and October 2025, and plan a second wave for September 2026. Quantitative analyses and mixed-methods integration are ongoing. Conclusions: PICAR is among the first studies to comprehensively investigate patient journeys and associated costs among children with different SHCN. The findings inform improvements in routine care delivery, support development of interventions to strengthen integrated care, and provide guidance for health policy, ultimately improving outcomes for children with SHCN and their caregivers. Clinical Trial: not applicable

  • Background: Quality indicators in primary care remain predominantly disease-specific and professionally defined, with limited incorporation of what matters most to people living with multiple long-term conditions (MLTC) and their caregivers. Existing frameworks and quality standards provide important conceptual direction, but few produce a pragmatic set of ready-to-use indicators. Objective: To co-develop a set of disease-agnostic quality-of-care indicators with people living and caring for those with MLTC that can pragmatically inform service improvement in primary care. Methods: This protocol describes a three-round modified RAND/UCLA Appropriateness Method (RAM) study. The first round will evaluate the importance of candidate indicators through an online questionnaire to patients, caregivers and expert healthcare professionals. Indicators without agreement or requiring revision will proceed to a structured consensus meeting (round 2) with subsequent rerating rounds (round 3) until consensus is reached. Results: This RAM study is currently underway, with planned completion in late 2026. Fifty-four candidate indicators have been generated through a scoping review of published quality indicator development studies and a qualitative interview study with 21 patients and caregivers living with MLTC. Ongoing patient and public involvement and engagement with four community partners has further informed the study design, interpretation of multi-stage findings, and refinement of candidate indicators. The indicators have been mapped to a structure-process-outcome quality framework and will be taken forward into a modified RAND/UCLA Appropriateness Method process. Conclusions: This study will generate a set of co-designed and implementation-oriented primary care quality indicators for MLTC. The final indicator set is intended to support future measurement, quality improvement, and later field testing in real-world primary care systems.

  • Background: The increasing shortage of skilled nursing staff, growing documentation demands, and rising complexity of care processes in long-term residential care highlight the need for digital solutions that support nursing workflows while remaining adaptable to real-world care environments. Augmented reality (AR) technologies have the potential to improve access to context-sensitive information and support documentation processes directly at the point of care. In particular, AR-supported clinical dashboards may enable the real-time visualization of relevant patient information during nursing activities without interrupting ongoing care activities or requiring additional device interactions. Although previous studies have explored AR applications in nursing education and documentation, little is known about the usability, practical applicability, and implementation requirements of AR-supported dashboard systems in long-term residential care settings. Furthermore, the participatory development of such technologies together with nursing professionals remains underexplored. Objective: This study aims to explore nursing professionals’ expectations, perceived potentials, barriers, and practical requirements regarding the participatory development and potential use of an AR-supported clinical dashboard in long-term residential care. The project seeks to identify user-centered design principles and implementation requirements for the iterative development of an AR-supported information and documentation system tailored to nursing practice. Methods: The study follows an exploratory qualitative design embedded within a participatory and agile development process. The theoretical framework is informed by the updated Consolidated Framework for Implementation Research (CFIR). Data collection will take place in a long-term residential care facility in Saxony-Anhalt, Germany, which serves as a real-world laboratory for the iterative development and evaluation of the AR-supported clinical dashboard. Data collection and iterative development processes are conducted between 2025 and 2027. Initial focus groups will explore general expectations, barriers, and potential use scenarios without a technical prototype. In subsequent development cycles, progressively refined prototypes will be integrated into the discussions to obtain structured user feedback for iterative system adaptation. Focus groups will be audio recorded, transcribed verbatim, and analyzed using the Gioia methodology to identify first-order concepts, second-order themes, and aggregate dimensions. MAXQDA software will support qualitative data analysis. Results: The project started in April 2025 with an initial setup and development phase. The study is currently in the early development stage, with data collection and iterative prototype development ongoing and scheduled to continue until March 2027. Conclusions: The study is expected to generate practice-oriented insights into the participatory development and implementation of AR-supported clinical dashboards in long-term residential care. The findings may contribute to the development of context-sensitive and workflow-oriented digital solutions that support workflow integration and facilitate context-sensitive information access within routine nursing care. Clinical Trial: The study will be registered in the German Clinical Trials Register (DRKS).

  • Background: Extensive research consistently reveals significant health disparities among Black communities in Canada, highlighting a gap in the publicly funded universal healthcare model in providing equitable care. Such a system should ensure that healthcare needs are adequately addressed for all residents. However, anti-Black racism across all sectors of Canadian society and deficient access to health services have been identified as contributors to poor health outcomes among Black people living in Canada. Black communities are also challenged with over-exposure to adverse social determinants of health, such as poverty, inadequate housing, and high rates of racialized systemic violence, which increase susceptibility to both physical and mental health conditions. The ongoing systemic health inequities experienced by Black communities in Canada highlight the lack of understanding of these communities’ health needs. Currently, there is no comprehensive picture of the relationship between the social determinants of health and health outcomes of Black communities in Canada. Objective: This paper outlines a protocol for a scoping review that aims to explore the breadth of the literature that examines the impact of social determinants of health on physical and mental health outcomes among Black communities in Canada, as well as the gaps in this literature. Methods: The scoping review adopts the approach outlined by Arksey and O’Malley. In addition, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) framework will be utilised to ensure comprehensive reporting of the review’s methods and findings. This review aims to investigate the scope and breadth of research gaps on the impact of social determinants of health on physical and mental health outcomes among Black communities in Canada. The databases searched to identify studies that meet the selection criteria were MEDLINE, Embase, APA PsycINFO, CINAHL Plus, Sociological Abstracts, PAIS Index, and Web of Science Core Collection. A two-stage screening process identified relevant articles and the information extracted from the articles will be iteratively refined. The review uses thematic and descriptive analyses to meet scoping aims. Results: The title, abstract, and full-text screening was concluded in November 2025. Fifty-six articles were selected following a two-stage screening process. Data collection and analysis are in progress and are expected to be completed by May 2026. Drafting of the manuscript will be done thereafter with the findings from the scoping review expected to be provided for peer review between July and September 2026. Conclusions: The scoping review will help inform policy, practice, and research on the impact of the social determinants of health on Black people in Canada. The findings will also provide important information on the systemic causes of poor health outcomes for Black people in Canada.

  • Background: Acute kidney injury (AKI) is a common and serious complication following cardiothoracic surgery, occurring in up to 30% of patients. Cardiac surgery-associated AKI (CSA-AKI) is associated with increased morbidity, mortality, and progression to chronic kidney disease. Currently, no pharmacological interventions have been approved for clinical use to reduce the incidence or severity of CSA-AKI. It is hypothesized that early modulation of the inflammatory response, triggered by the release of damage-associated molecular patterns during surgery, may improve renal outcomes. Ilofotase alfa, a recombinant human alkaline phosphatase, has demonstrated potential to attenuate renal injury through its immunomodulatory effects in animal studies. Objective: This manuscript presents the protocol for a Phase 2 clinical trial evaluating the safety and efficacy of ilofotase alfa in preventing renal damage following cardiac surgery. Methods: This is a Phase 2, multi-centre, randomized, double-blinded, placebo-controlled trial employing a two-arm, parallel-group design. Adult patients at risk for CSA-AKI undergoing complex open-heart surgery will be randomized to receive two intravenous doses (2x128 mg) of ilofotase alfa or placebo, just before and after surgery. Ethics and Dissemination The study has been approved by all relevant institutional review boards and independent ethics committees. It will be conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and all applicable regulatory requirements. The results of this trial will inform the potential role of ilofotase alfa in preventing cardiac surgery associated renal injury and improving longer-term clinical outcomes and will be published in a peer-reviewed scientific journal. Results: The primary endpoint is the serum creatinine ratio, defined as the highest serum creatinine level within five days postoperatively relative to the preoperative baseline, with the occurrence of major adverse kidney events up to day 60 as the secondary endpoint. In addition, safety assessments and the AKI as defined by the KDIGO creatinine-criterion will be assessed. Patients will be followed for a total of 60 days. Conclusions: The results of this study will will enable us to assess safety as well as the efficacy of ilofotase alfa in attenuating renal injury and improving long-term renal outcomes. Clinical Trial: Trial registration numbers EUCT Number:2023-505859-45 US IND Number:117 605 ClinicalTrials.gov ID:NCT06168799

  • Background: Painful diabetic peripheral neuropathy (P-DPN) is a common and disabling complication of diabetes affecting a substantial proportion of patients and significantly impairing quality of life. Current pharmacological treatments provide only modest pain relief and are often associated with side effects that limit long-term adherence. Consequently, there is a critical need for novel, mechanism-based treatment approaches that target the underlying neurobiological processes of chronic pain. Objective: The aim of this study is to investigate the efficacy and underlying neurophysiological mechanisms of source-localized EEG neurofeedback (EEG-NF) in individuals with P-DPN compared with a sham neurofeedback control condition. Methods: The study is a randomized, multi-center, blinded, and sham-controlled clinical trial investigating the treatment efficacy of source localised EEG-NF in individuals with P-DPN. Fifty-five subjects with either type 1 or type 2 diabetes, diabetic neuropathy (DPN) and an average pain ≥4 on a Numeric Rating Scale (NRS) of 0–10 will be randomized 1:1 to receive either active EEG-NF or sham NF across 10 sessions. The primary outcome is the change in mean 7-day average pain intensity (NRS) from baseline (T0) to post-intervention (T1) measured by an electronic pain diary. Secondary outcomes include changes in different aspects of neuropathic pain (Neuropathic Pain Scale (NPS), Pain Catastrophizing Scale (PCS), sleep interference (PROMIS SF Sleep and Fatigue), mental health (PROMIS SF depression), and health-related quality of life (WHOQL-Brief). Neurophysiological outcomes will also be assessed using quantitative EEG and standardized low-resolution electromagnetic tomography (swLORETA) using predefined metrics of abnormal cortical activity, connectivity as well as the achieved degree of EEG normalisation. This trial will evaluate both the efficacy and potential mechanisms of EEG-NF in the treatment of P-DPN. Results: Ethical approval for the study was obtained by the Regional Committees on Health Research Ethics in Region of Southern Denmark (Projekt-ID S-20220074). Ethical approval date 17 May 2024, first patient first visit 14 August 2024. The data collection is expected to be done in December 2026. The trial is registered at ClinicalTrials.gov (NCT06603792). Conclusions: This trial will provide important evidence regarding the efficacy and neurophysiological mechanisms of EEG-NF as a non-pharmacological treatment for P-DPN. If effective, EEG-NF may represent a novel mechanism-based intervention targeting central pain processing abnormalities in P-DPN and contribute to the development of more personalized treatment approaches for chronic neuropathic pain. Clinical Trial: ClinicalTrials.gov (NCT06603792)

  • Background: CrossFit is a popular high intensity training modality combining weightlifting, gymnastics, and cardiovascular conditioning. Despite its benefits, concerns remain regarding musculoskeletal injury risk. Movement screening tests such as the Functional Movement Screen (FMS), Selective Functional Movement Assessment (SFMA), Y Balance Test (YBT), and Biering Sorensen Test have been proposed to evaluate mobility, stability, and motor control. However, their predictive validity in CrossFit athletes is not well established. Objective: This protocol describes a prospective cohort study designed to investigate the screening (predictive) value of movement and motor control screening test scores and their relationship with musculoskeletal injuries in CrossFit athletes Methods: A minimum of 142 male and female CrossFit athletes aged 18–45 years with at least six months of training experience will be recruited from Tehran training centers based on sample size calculation (G*Power, effect size = 0.25, power = 0.80, alpha = 0.05, plus 20% attrition). Baseline assessments will include standardized movement screening tests (FMS, SFMA, YBT, Biering Sorensen). The primary outcome is the occurrence of any new CrossFit related musculoskeletal injury during six months of prospective follow up, defined as any complaint leading to training modification, medical consultation, or absence from training for ≥24 hours. Injuries will be verified through bi weekly follow up calls and coach/medical staff communication. Statistical analysis: Logistic regression, Cox proportional hazards models, sensitivity, specificity, predictive values, and ROC curve analysis will be used to evaluate the predictive utility of screening scores. Results: This study will clarify whether movement screening scores can serve as reliable predictors of injury risk in CrossFit athletes Conclusions: This protocol will provide evidence on the role of movement screening tests in predicting musculoskeletal injuries among CrossFit athletes, with implications for injury prevention and athlete safety. Clinical Trial: NA

  • Background: Chest X-ray (CXR) based screening is critical for improving Tuberculosis (TB) case detection in high-burden settings, where a substantial proportion of cases are subclinical or asymptomatic with only radiographic evidence of TB. Although the WHO recommends the use of CXR for active TB screening among high-risk populations, access to conventional digital radiography remains limited in peripheral and resource-constrained settings. Recent advances in ultraportable, handheld X-ray devices offer a promising alternative to radiographic evaluation generating interest in their indigenization and ease of programmatic deployment. However, handheld X-ray devices require systematic validation against standard digital radiography for safer and efficient deployment Objective: This validation protocol describes the process for systematic evaluation of adequacy of image quality and diagnostic accuracy of CXR images for TB screening. The study aims to provide a standard comparison for evaluation of the quality of CXR images produced by ultraportable handheld X-ray against conventional digital X-ray systems. Methods: This protocol describes a cross-sectional paired comparison study to evaluate the image quality and diagnostic adequacy of CXRs acquired using handheld devices relative to standard digital radiography. Adults aged ≥18 years indicated for CXR examination will be consecutively enrolled until a target enrollment (sample size) of 100 participants is reached. Each participant will undergo two standard postero-anterior CXR examinations, one using a handheld X-ray device and one using a standard digital system. Anonymized images will be independently assessed by two senior radiologists using image quality criteria, including anatomical coverage, spatial resolution, exposure, penetration, positioning, and overall interpretability, that would standardize the CXR for reading and interpretation of Chest X-ray including detection of lung abnormalities consistent with TB. The primary outcome will be the limits of agreement between handheld and standard devices based on overall image quality scores. Agreement in abnormality detection and inter-reader reliability will be assessed using Cohen’s kappa statistics, with standard digital radiography as the reference. Results: The study has been initiated at ICMR- Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna. The study protocol underwent ethical review and was approved by the Institutional Ethics Committee. Conclusions: The proposed protocol helps to create a common pathway for normalizing and standardizing portable hand-held Xray by providing a broad overview on the parameters to be assessed, the methodology to be used for comparison for successful deployment in remote areas without compromising on accuracy of detection.

  • Comparative Assessment of Natural Background Radiation Levels in Village Sawangi: A Study Protocol

    Date Submitted: May 7, 2026
    Open Peer Review Period: May 11, 2026 - Jul 6, 2026

    Background: The natural sources contribute about 82 percent of the total radiation dose to human beings. These levels are usually low; however, chronic exposure to even low-level radiation is a social health concern as it may cause such biological effects as DNA damage or cancer. Environmental radioactivity is a common occurrence, as it is caused by radionuclides present in the crust of the Earth, the atmosphere and the cosmic environment, which are classified as primordial, cosmogenic or anthropogenic. Radionuclides such as Uranium-238, Thorium-232, and Potassium-40 dates back to the formation of the Earth and those such as Carbon-14 are produced by the cosmic ray interactions. Although there is high importance of monitoring these levels, there is a clear deficiency of documented data of baseline in rural settlements in Central India, that is in the Wardha district. To verify adherence to the safety limits of 1 mSv/year (to the population, above the natural background) of the safety of the radioactivity introduced by the Atomic Energy Regulatory Board (AERB) and the International Commission of Radiological Protection (ICRP) it is therefore necessary to establish a local radiation profile of Village Sawangi. Objective: The objective of this study is to assess natural background radiation levels in Village Sawangi by measuring radiation exposure at strategic residential, agricultural, water-source, and construction locations using calibrated survey instruments. The study further aims to evaluate spatial variation in radiation distribution, estimate the annual effective dose using UNSCEAR conversion coefficients, identify potential radiation hotspots through spatial analysis, and compare the measured levels with national and international radiation safety standards established by the AERB and ICRP. Methods: The proposed observational research will be carried out in the developing rural-to-semi-urban village of Village Sawangi in the Deoli tehsil where land use and construction trends are rapidly evolving. A systematic survey of 15-20 strategic locations will be used in the research which will include: residential houses, agriculture farms, water sources, and construction sites. Sites will be chosen according to certain inclusion criteria with the consideration of commonly occurring village habitats without known initial radiation contamination that can be measured repeatedly. On the other hand, any sites that contain known radioactive waste industrial or medical or personal property on which consent is not given will be omitted. Calibrated portable gamma survey meters, ionization-based survey meters and TLD badge will be the data collection instruments. These quantifiable exposure rates will then be translated into an annual effective dose by use of the standard conversion coefficients that are offered by the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Results: the study is to measure radiation levels at strategic points using calibrated survey meters, to assess spatial variation across residential and agricultural zones, to calculate the annual effective dose using UNSCEAR conversion coefficients, and to identify radiation hotspots through spatial analysis. Conclusions: This study will provide the first systematic assessment of natural background radiation levels in Village Sawangi, establishing a vital radiological baseline for a developing rural-to-semi-urban area. By identifying potential radiation "hotspots" and calculating the annual effective dose for residents, the research will determine whether the local environment complies with the safety limits of 1 mSv per year set by the AERB and ICRP. Ultimately, these findings will contribute to broader regional radiation mapping and serve as a critical reference for future public health surveillance and epidemiological research in the Wardha district. Clinical Trial: NA

  • Background: The Ending the HIV Epidemic (EHE) initiative remains a national priority in the United States (U.S.), aiming to reduce new HIV infections by 90% by 2030. As we cross the initiative’s midpoint, there has been a renewed commitment to strengthening the HIV workforce’s capacity to plan, implement, and sustain effective HIV prevention, treatment, and care interventions. Despite substantial improvements in HIV outcomes, uneven implementation of evidence-based interventions reflects persistent gaps between available evidence and its translation into locally actionable practice. Achieving EHE goals requires tailoring implementation to the diverse epidemiological, social, and structural conditions shaping HIV outcomes across jurisdictions. Research increasingly highlights the value of integrated, contextual data to strengthen public health decision-making. Linking indicators spanning multiple conceptual domains across regional, local and individual levels can support a more robust understanding of the distinct drivers of HIV outcomes, yet existing data systems remain fragmented across domains and scales. A harmonized, multisource, multilevel database is therefore essential to support targeted, needs-based and data-driven implementation under the EHE initiative. Objective: This project has two objectives: (1) to build a high-quality contextual database integrating multiple sources of public data using transparent, replicable, and updateable methods, and (2) to develop and document systematic workflows for ongoing database updates, quality assurance, and to support future use aligned with open-science frameworks and standard data practices. Methods: This project will follow best practices in data architecture, acquisition, standardization, and quality assurance. For Objective 1, we will integrate data across multiple geographic levels (e.g., ZIP code, county) for the years 2020-2025, with measures categorized into conceptual domains (e.g., epidemiologic, sociodemographic) guided by established theoretical frameworks to facilitate future analyses. For Objective 2, we will develop a tiered data structure to enable transparent and reproducible data management, using a GitHub repository to store all documentation, processing scripts, and quality assurance logs to align with open science practices. Database construction and quality assurance methods were informed by targeted literature reviews in PubMed. Data sources will be identified from three inputs: existing data repositories, datasets identified through targeted literature reviews, and reports or grey-literature with consistent formatting and permissive terms of use suitable for web scraping. Stakeholder engagement will be integrated through all phases of database development, informing variable selection, usability, and validation to enable iterative refinement and revision. Results: Literature reviews were conducted from October to November of 2025, to inform database construction methods, source identification, and protocol development. Data acquisition will begin in May 2026. Conclusions: This contextual database will provide a reproducible and scalable data resource to support public health planning and advance implementation science by enabling more context-responsive decision-making under the EHE initiative.

  • Background: Cerebral palsy (CP) is a common motor disability in children, and it refers to a group of disorders that affect a child’s ability to move, maintain balance and posture. Children with CP-related motor disorders experience disturbances of sensation, perception, cognition, communication, and behaviour, that are due to epilepsy. They may also have secondary musculoskeletal problems. Interprofessional team is needed to manage CP. However, in KwaZulu-Natal, rehabilitation services are fragmented, with departments working in isolation. Thus, there is a need to develop an interprofessional model of care responsive to the needs of those involved in the care of children with cerebral palsy (CWCP). Objective: To propose an evidence-based interprofessional model of care responsive to the needs of children with cerebral palsy in KwaZulu-Natal. Methods: This study will employ a phased sequential multi-method approach, with Phases 1, 2 and 3 having two, three and three objectives, respectively. Phase one (Objectives 1-2) will be conducted through a systematic scoping review to map the current evidence on the interprofessional rehabilitation practices utilized in low- and middle-income countries (LMICs) to manage CP, complemented with in-depth interviews (IDIs) on how Health Care Practitioners (HCPs) in KwaZulu-Natal manage children with CP. Using IDIs, FGDs and survey questionnaires, Phase two (Objectives 3- 5) will focus on exploring caregivers’ perspectives on the rehabilitation of children with CP, their lived caregiving experiences, and determine the level of caregiver burden. Phase three will use phases one and two results to propose and validate a model of care through a Delphi technique. The study has obtained ethics approval and gatekeeper permission from the University of KwaZulu-Natal’s Biomedical Research Ethics Committee and the Provincial Department of Health, respectively. Results: Results of this study will be disseminated through publications in peer-reviewed journals, conference presentations and the thesis archived in the University’s library repository. Conclusions: This study is anticipated to provide an evidence-based interprofessional model of care responsive to the needs of children with CP, given that models used in high-income countries may not be appropriate for Low- and Middle- Income Countries’ contexts.

  • Background: Background: The integration of mental health services into primary health care is a pivotal strategy for reducing the treatment gap in low- and middle-income countrie. Despite strong global policy endorsement, implementation remains inconsistent and is shaped by a complex interplay of health system, sociocultural, and contextual factors. Qualitative evidence capturing stakeholder perspectives on these factors has not been synthesised in a theory-informed manner, limiting the depth and policy relevance of existing reviews. Objective: Objective: This review aims to synthesise qualitative evidence on individual, interpersonal, organisational, and policy-level factors that influence the integration of MHS into PHC in LMICs. Methods: Methods: This protocol adheres to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines and the Joanna Briggs Institute (JBI) methodology for qualitative systematic reviews. A comprehensive search will be conducted in PubMed, Embase, Web of Science, Scopus, CINAHL, and the Cochrane Library for studies published from January 2000 to December 2025. Eligible studies will include qualitative and mixed-methods research involving key stakeholders in primary mental health care in LMICs. Two independent reviewers will screen records, extract data using JBI SUMARI, and appraise study quality using the JBI Critical Appraisal Checklist for Qualitative Research. Data synthesis will employ the JBI meta-aggregation approach, with findings organised using a socio-ecological framework. Confidence in synthesised findings will be assessed using the ConQual approach. Results: Results: The review is currently in progress. The protocol was registered in PROSPERO (CRD42024533735) before commencement of formal screening or data extraction. Preliminary scoping searches have been conducted to inform the search strategy. Database searching, title and abstract screening, full-text assessment, and data extraction are planned for completion by the end of 2026. Synthesised findings are expected to be published in 2026. Conclusions: Conclusions: This review will generate contextually grounded, policy-relevant evidence to support the design and scale-up of integrated MHS in resource-constrained settings. Findings will identify modifiable factors affecting integration across multiple health system levels and inform the development of evidence-based implementation strategies in LMICs. Clinical Trial: PROSPERO CRD42024533735

  • Background: Refugee and newcomer older adults experience multidimensional forms of complexity shaped by intersecting medical, social, and system-level factors that are not fully captured in biomedical frameworks. However, how this complexity is conceptualized across the literature remains unclear and fragmented. Objective: This scoping review aims to examine what is known in the literature about social, functional, and system-level complexity in complex care needs of refugee and newcomer adults aged 60 and older, focusing on dimensions beyond strictly medical indicators. Methods: This scoping review will follow the JBI methodology and report the findings using the PRISMA-ScR checklist. Key databases (MEDLINE, Embase, CINAHL, AgeLine, PsycINFO, Scopus, Web of Science) will be searched using controlled vocabulary and text terms. Two reviewers will independently screen titles, abstracts, and full texts, with discrepancies resolved through discussion and consensus. Included studies will examine adults aged ≥60 years (or as defined by study authors) with complex care needs and describe or measure social, functional, or system-level aspects of complexity beyond medical indicators, across any care or community setting. Only peer-reviewed literature from 2005 onward will be included; Grey literature will be excluded to maintain consistency in reporting quality and focus on peer reviewed evidence. Data will be charted descriptively and thematically, and a consultation phase with clinicians and refugee and newcomer older adults will be conducted to validate and refine emerging themes, clarify conceptual domains, and ensure findings reflect lived and clinical perspectives. Results: This review is expected to identify heterogeneous definitions and frameworks of multidimensional complexity and map key domains across disciplines and care settings. Findings will highlight gaps in how refugee and newcomer-specific factors are represented and inform more context-sensitive models of complex care. Conclusions: This review will synthesize current knowledge on social, functional, and system-level complexity in complex care needs of refugee and newcomer adults aged ≥60 and older. Results will highlight conceptual gaps, inform potential subsequent concept analyses, and provide guidance for research, policy, and practice to support more comprehensive, person-centered approaches in clinical and social care settings.

  • Background: Acromial stress fractures represent a clinically important complication in reverse shoulder arthroplasty (RSA) with reported incidences up to 11%. Although modern implants improve the current situation, the precise role that load transfer plays in acromial fracture risk in RSA is not completely understood. To date, there is no preoperative method for risk stratification using individualised patient-specific factors. Objective: We present a prospective, imaging-based, radiologist-assisted finite element framework to estimate acromial stress risk after RSA. This protocol outlines its implementation and a first feasibility analysis. Methods: Ten to fifteen consecutive patients scheduled for elective primary RSA will undergo standardised high-resolution CT and 1.5T/3T MRI. Rotator cuff integrity will be graded using the Goutallier classification; the ordinal scores will be aggregated into a patient-specific Cuff Deficiency Index (CDI) using a preliminary weighting scheme (supraspinatus 0.40, infraspinatus 0.30, subscapularis 0.20, teres minor 0.10) subject to validation on the pilot cohort. This index will serve as a direct scalar multiplier for deltoid loading parameters in the finite element model. Patient-specific geometries will be created from HU-mapped cortical bone (CT) and MRI-derived deltoid anatomy. Physiological and RSA loading scenarios will be simulated in FEBio v3.x under quasi-static conditions. Acromial von Mises stresses will be extracted in anatomically defined Levy zones. Morphometric and stress-based parameters will be correlated with six-month postoperative radiographs. This study is registered on ClinicalTrials.gov (NCT07545707). Results: Patient recruitment and finite element simulations have not yet commenced. Data collection is scheduled to begin in the second quarter of 2026. This protocol paper reports the planned workflow and analysis strategy only. Conclusions: By prospectively integrating radiological grading of rotator cuff integrity into a patient-specific finite element workflow, this study aims to explore whether preoperative imaging and biomechanical modelling can identify anatomical patterns associated with increased acromial stress in RSA. Clinical Trial: ClinicalTrials.gov NCT07545707

  • Background: Radiology is an important branch of healthcare as it allows one to diagnose and plan treatment correctly. The quality of the image and patient safety should be ensured by following standardized Quality Assurance (QA) schemes. In this study we will compare the QA guidelines as stipulated by the AERB (Atomic Energy Regulatory Board), IAEA (International Atomic Energy Agency) and AAPM (American Association of Physicists in Medicine) to determine their applicability and challenges encountered in their implementation in Indian environments. The main QA (Quality Assurance) parameters are examined in order to determine the gaps and constraints. On this basis, a combined QA (Quality Assurance) protocol is established to enhance compliance, equipment operation and patient safety. Objective: To compare national and international QA (Quality Assurance) protocols (AERB (Atomic Energy Regulatory Board), AAPM (American Association of Physicists in Medicine), IAEA (International Atomic Energy Agency)). Identify the gaps, variations, and limitations in the current QA (Quality Assurance) practices, develop a comprehensive standardized QA (Quality Assurance) protocol. Methods: This descriptive research will be done in DMIHER, Sawangi Meghe, India, to methodologically examine what is currently being practiced in terms of Quality Assurance (QA) measures of radiation departments against both national and international standards. A step-by-step methodology will be adopted. AERB (Atomic Energy Regulatory Board) will first review its procurement and QA (Quality Assurance) policies to know the present radiation safety practice and equipment performance standards in India. It will be preceded by a closer inspection of QA (Quality Assurance) systems and audit programs by IAEA (International Atomic Energy Agency) and AAPM (American Association of Physicists in Medicine) with regards to the frequency of testing, the level of performance, and quality control measures. A comparative study will help to find differences, gaps, and limitations in AERB (Atomic Energy Regulatory Board) guidelines. Recommendations will be offered and a single QA (Quality Assurance) system will be worked out based on the findings. Results: The study has received ethical approval and will begin in November 2025. Data collection from selected radiation units will be completed by the end of 2025 through review of existing QA (Quality Assurance) protocols. Comparative analysis with AERB (Atomic Energy Regulatory Board), IAEA (International Atomic Energy Agency), and AAPM (American Association of Physicists in Medicine) standards will identify gaps with final analysis and recommendations expected by November 2026. Conclusions: The study will present a comparison of QA (Quality Assurance) protocols with AERB (Atomic Energy Regulatory Board), IAEA (International Atomic Energy Agency), and AAPM (American Association of Physicists in Medicine) standards, identifying gaps and inconsistencies in current practices. It will support the development of standardized QA (Quality Assurance) guidelines for routine use, improving regulatory compliance, enhancing radiation safety for patients and staff, and ensuring greater accuracy in diagnostic imaging.

  • Background: Loneliness is increasingly recognized as a major public health concern in higher education with nearly one in four students feeling lonely most or all of the time, with 80% reporting moderate-to-severe loneliness. Compassion from others, defined as receiving warmth, care, and understanding, may buffer loneliness. Yet, many students may struggle with receiving compassion due to shame, self criticism, and fear of compassion, which hinder their capacity to engage in supportive relationships. Objective: The proposed scoping review (ScR) aims to map the existing literature on compassion from others and its relationship to loneliness among university students, clarify conceptual boundaries, identify psychological and institutional influences, and highlight gaps to inform future research and intervention development. Methods: This protocol for the scoping review follows PRISMA ScR guidance. Eligibility criteria are structured using the PI(E)COS framework. Searches in the final scoping review (ScR) will be conducted in PsycINFO, PubMed, Scopus, Web of Science, ERIC, ProQuest, CINAHL and Google Scholar. This protocol proposes the methodological framework of Arksey and O’Malley with enhancements from the Joanna Briggs Institute (JBI) for use in the anticipated scoping review. Jointly and consistent with Joanne Briggs Institute (JBI) guidance for ScR, we will aim to map the breadth and nature of existing research; therefore, no critical appraisal or risk of bias assessment will be undertaken, as these are not required for scoping reviews unless justified by specific objectives Results: The ScR protocol will document the predicted tools for mapping definitions and measures of compassion from others; the prevalence and correlates of loneliness; psychological barriers, such as shame and threat sensitivity; and institutional contributors, such as academic culture and supervisory relationships. Conclusions: This ScR protocol provides the initial outline of the future ScR methods of compassion from others research in higher education. Findings will support the development of compassionate academic environments that foster students’ sense of belonging and reduce their loneliness. Clinical Trial: OSF portal with access from the link https://osf.io/4tnqc/overview

  • Background: Operative vaginal birth (OVB) is recognised by the World Health Organization as one of the seven critical components of basic obstetric and neonatal emergency care¹. The global rate of operative vaginal birth has declined significantly over the past two decades². This decline has been attributed to the heightened attention given to its complications and the associated medicolegal concerns³, negative perceptions among service users⁴, and insufficient training in the use of instruments or in complex interventions⁵. Operative vaginal birth is associated with better maternal and neonatal outcomes than caesarean section at full cervical dilatation when performed by an experienced operator in an appropriate setting⁶. In particular, among women requiring operative vaginal birth, the incidence of postpartum haemorrhage is reduced and the length of hospital stay is shorter. In addition, their newborns are less likely to require admission to the neonatal intensive care unit⁶. Operative vaginal delivery is typically undertaken in urgent clinical scenarios, thereby constraining the time available for adequate preparation and informed consent.⁷. Nevertheless, it is crucial to ensure that women and their companions feel informed and supported throughout this experience⁸,⁹. A recent review suggests that women may perceive operative vaginal birth positively when they receive effective communication from the medical team and feel involved in the decision-making process¹⁰. In Spain, approximately 14% of births are operative vaginal births, of which around 60% are performed using vacuum extraction¹¹. Proficiency in the application of the vacuum device depends on the level of exposure of junior obstetricians to situations in which they can learn the procedure under the supervision of more experienced practitioners. Obstetric experience is directly related to the number of times operative vaginal birth is performed on real patients. However, this learning approach raises ethical concerns and has driven the development of simulation-based training programmes in several countries. These programmes aim to ensure that obstetric trainees acquire both the technical and non-technical skills necessary to perform vacuum extraction safely and appropriately¹³. Objective: The objective of this study is to evaluate the clinical impact of a structured simulation-based training programme in vacuum-assisted vaginal birth on maternal and neonatal outcomes, using a stepped-wedge interrupted time-series design. Primary study objectives: 1. To establish the rate of cup detachment (pop-off) associated with vacuum-assisted vaginal birth (Kirkpatrick Model Level III). 2. To determine the incidence of neonatal injuries associated with vacuum-assisted vaginal birth. 3. To determine the incidence of perineal tears associated with vacuum-assisted vaginal birth. 4. To assess course satisfaction and reproducibility using a Likert scale (Kirkpatrick Model Level I). Secondary study objectives: 1. To determine the proportion of obstetricians who have received formal simulation-based training in vacuum-assisted vaginal birth. 2. To identify the type of vacuum device most commonly used in maternity units in our setting. 3. To establish the rate of sequential instrumentation (Kirkpatrick Model Level III). 4. It would be useful to clarify whether the objectives of the observational study differ before and after the intervention. 5. To determine the percentage of obstetricians who improve their confidence in the technique used, measured using a Likert scale (levels of concern and agreement) (Kirkpatrick Model Level II). 6. To determine the percentage of acquired knowledge retained at least six months after training (Kirkpatrick Model Level III). Methods: Study Design Study Design This study is a multicentre, quasi-experimental evaluation of an educational intervention using a stepped-wedge interrupted time-series design. The design was selected to assess the impact of a structured simulation-based training programme in vacuum-assisted vaginal birth, implemented sequentially across participating centres. Randomisation at the individual clinician or institutional level was not feasible due to the educational and organisational nature of the intervention. The stepped-wedge design allows all centres to ultimately receive the intervention while contributing both pre-intervention (control) and post-intervention (exposed) data, and enables adjustment for secular time trends and between-centre variability. The study protocol adheres to the STROBE guidelines for observational studies and to methodological recommendations for stepped-wedge and interrupted time-series designs. Study Setting The study will be conducted in maternity units across Spain participating in the Registro Español de Morbimortalidad Materna y Perinatal (REMMP), a national registry that systematically collects maternal and neonatal outcome data. Participating hospitals represent a range of institutional characteristics, including differences in delivery volume, geographic location, and level of obstetric care, thereby enhancing the external validity and generalisability of the findings. Each centre will implement the intervention according to a predefined staggered schedule established prior to study initiation. Intervention The intervention consists of a standardised simulation-based training programme in vacuum-assisted vaginal birth, conceptualised as a complex clinical and educational intervention. The programme includes: ● Access to the theoretical part of the course was provided online one month in advance. ● A structured face-to-face practical workshop (approximately 1 hour) ● High-fidelity simulation of vacuum-assisted vaginal birth ● Use of a standardised technical skills checklist ● Supervised hands-on practice with expert feedback ● Training of local instructors using a train-the-trainer model to ensure sustainability ● An opinion survey evaluating perceived usefulness and effectiveness of the simulation activity The training curriculum focuses on: ● Appropriate clinical indications for vacuum-assisted vaginal birth ● Selection and correct placement of the vacuum cup at the flexion point ● Generation and regulation of negative pressure ● Traction technique and coordination with maternal effort ● Recognition of failed attempts and criteria for abandoning the procedure ● Appropriate escalation to alternative delivery methods To minimise contamination during implementation, no clinical outcome data will be collected during the intervention delivery (washout) period, when varying proportions of clinicians within each centre are undergoing training. Participants Study Population The study population will include women and neonates undergoing an attempted vacuum-assisted vaginal birth at participating centres during the study period. Inclusion Criteria ● Maternal age ≥18 years ● Vaginal birth at a participating centre ● Attempted operative vaginal birth using a vacuum extractor ● Maternal informed consent Exclusion Criteria ● Gestational age < 37 weeks ● Multiple pregnancy ● Use of a vacuum device exclusively during caesarean section Study Periods For each participating centre, the study timeline will be divided into three phases: 1. Pre-intervention period: six months prior to implementation of the training programme, during which clinical outcome data are collected. 2. Intervention implementation (washout) period: training delivery phase; no clinical outcome data collected to minimise contamination. 3. Post-intervention period: six months following completion of training, during which clinical outcome data are collected. This structure allows comparison of outcomes before and after exposure to the intervention while controlling for secular trends. Outcome Measures Primary Outcome The primary outcome is failure of vacuum-assisted vaginal birth as the first intended instrument, defined as: ● Use of a second operative instrument, or ● Conversion to caesarean section following attempted vacuum extraction We focused on the collection of the pop-off rate in order to assess technical failures of the procedure. This outcome was selected due to its clinical relevance and consistency with international literature on operative vaginal birth. Secondary Outcome Maternal outcomes ● Sequential instrumentation ● Caesarean section ● Total instrument application time (minutes) ● Number of instrument applications ● Number of traction pulls required ● Episiotomy ● Perineal trauma ● Cervical tear requiring suturing ● Postpartum haemorrhage (estimated blood loss ≥ 1000 mL) ● Use of general anaesthesia or regional anaesthesia Neonatal outcomes ● Apgar score < 7 at 5 minutes ● Umbilical arterial pH < 7.10 ● Shoulder dystocia ● Neonatal scalp injuries (cephalohematoma or subgaleal haematoma) ● Admission to neonatal intensive care unit ● Neonatal hyperbilirubinaemia requiring phototherapy at a mínimum Covariates The following maternal, fetal, and procedural variables will be collected to characterise the study population and adjust analyses as appropriate: ● Participant age (years) ● Country of professional training (Spain, Europe, outside Europe) ● Operator seniority (attending physician or resident) ● Operator experience (years of professional experience) ● Training method (simulation or in vivo) ● Indication for operative vaginal birth ● Type of obstetric vacuum device used ● Number of cup detachments (pop-off) ● Presence of caput succedaneum ● Analgesia use ● Fetal head position Data Collection and Management Clinical data will be collected retrospectively and prospectively from routinely recorded medical records at each participating centre. All data will be anonymised prior to entry into a secure, password-protected electronic database accessible only to authorised members of the research team. Data quality checks and consistency reviews will be performed regularly throughout the study period. Statistical Analysis Analyses will be conducted on an intention-to-treat basis at the centre level, whereby each hospital will be considered exposed to the intervention from the predefined post-intervention period, regardless of individual clinician attendance. Statistical Framework and Notation Let i index individual births (i = 1,…, N), h(i) denote the hospital (cluster), and t(i) the discrete time period (step). Exposure to the intervention is defined at the hospital–time level. Hospitals are considered unexposed during the pre-intervention period and exposed from the post-intervention period onwards. Primary Analysis The primary outcome will be analysed using modified Poisson regression with a log link and robust (sandwich) variance estimation to estimate adjusted risk ratios (RRs). Models will include: ● Fixed effects for hospital to account for clustering ● Fixed effects for time period to adjust for secular trends Secondary Analyses Secondary binary outcomes will be analysed using the same modified Poisson framework. Count outcomes will be analysed using Poisson or negative binomial regression as appropriate. Continuous outcomes will be analysed using linear regression or transformed if required to meet model assumptions. Sensitivity analyses will explore alternative specifications of time (categorical versus continuous) and the impact of delayed or incomplete implementation at individual centres. All analyses will be performed using R statistical software, with a two-sided significance level of 0.05. Sample Size Considerations Formal sample size calculation for stepped-wedge designs is complex due to clustering and repeated measures. Therefore, a pragmatic approach was adopted. Based on published literature, the baseline failure rate of vacuum-assisted vaginal birth as the first intended instrument is estimated at approximately 20%. The study is designed to detect a clinically meaningful relative reduction to 10–12% following implementation of the training programme. Assuming an intracluster correlation coefficient between 0.05 and 0.10 and accounting for clustering and temporal effects, a minimum sample size of approximately 3,000 vacuum-assisted vaginal births is considered sufficient to detect the anticipated effect size with adequate statistical power. Given the national scope of REMMP, the expected number of eligible cases during the study period is anticipated to exceed this threshold. Ethics Approval The study involves the analysis of routinely collected anonymised clinical data. Ethical approval was granted by the CEIm Girona (Code: 2024.070) on 05/08/2024. All participants sign a written informed consent form authorising the use and sharing of their data for research purposes. All procedures are conducted in accordance with national data protection regulations and the Declaration of Helsinki. Multimedia Appendices ● Multimedia Appendix 1: SPIRIT schedule of enrolment, intervention, and assessments ● Multimedia Appendix 2: STROBE Checklist (for Observational Studies) References 1. Trends in maternal mortality: 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division [en línea]. 2019 [Consultado el 11 de octubre de 2021]. Disponible en: https://www.unfpa.org/featured-publication/trends-maternal-mortality-2000-2017. 2. Murphy DJ. Medico-legal considerations and operative vaginal delivery. Best Pract Res Clin Obstet Gynaecol 2019;56:114-24. 3. Feinmann J. Why do doctors still use forceps when they killed our baby? Daily Mail. 22 de febrero de 2010 [Consultado el 11 de octubre de 2021]. Disponible en: https://www.dailymail.co.uk/health/article-1253013/Forceps-killed-baby-doctors-using-them.html. 4. Gale A, Siassakos D, Attilakos G, et al. Operative vaginal birth: better training for better outcomes. BJOG 2014;121:643-4. 5. Registro Español de Seguridad Obstétrica 2021. Grupo Español de Seguridad Obstétrica. 6. Murphy DJ, Liebling RE, Verity L, et al. Early maternal and neonatal morbidity associated with operative delivery in the second stage of labor: a cohort study. Lancet 2001;358:1203-7. 7. Gale A, Siassakos D, Attilakos G, et al. Operative vaginal birth: better training for better outcomes. BJOG 2014;121:643–4. 8. RCOG. Operative vaginal delivery: green–top guideline No. 26 [en línea]. 2011 [Consultado el 11 de octubre de 2021]. Disponible en: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_26.pdf. 9. Mobbs N, Williams C, Weeks A. Humanising birth: does the language we use matter? [en línea]. 2018 [Consultado el 11 de octubre de 2021]. Disponible en: http://blogs.bmj.com/bmj/2018/02//humanising-birth-does-the-language-we-use-matter/. 10. NICE. Intrapartum care for healthy women and babies [en línea]. 2014 [Consultado el 11 de octubre de 2021]. Disponible en: https://www.nice.org.uk/guidance/cg190/resources/intrapartum-care-for-healthy-women-and-babies-pdf-35109866447557. 11. Registro Español de Seguridad Obstétrica 2022. Grupo Español de Seguridad Obstétrica. 12. Moreau R, Pham MT, Brun X, Redarce T, Dupuis O. Assessment of forceps use in obstetrics during a simulated childbirth. Int J Med Robot. 2008;4(4):373-80. Disponible en: https://doi.org/10.1002/rcs.222. 13. O'Grady JP, Pope CS, Patel SS. Vacuum extraction in modern obstetric practice: a review and critique. Curr Opin Obstet Gynecol. 2000;12(6):475-80. Disponible en: https://doi.org/10.1097/00001703-200012000-00003. 14. Vacca A. Reducing the risks of a vacuum delivery. Fetal and Maternal Medicine Review 2006; 17:4. DOI: I O./ O I 7/S096553950600 l 823 Appendix 1. SPIRIT Schedule of Enrolment, Intervention, and Assessments Title: SPIRIT schedule for the stepped-wedge simulation-based training programme in vacuum-assisted vaginal birth Assumptions used for the schedule: ● Step duration: Step duration varies according to the period ● Total periods per centre: 3 periods (t1-t3) ● Washout period: training implementation; no clinical outcome data collected ● Each centre transitions once from pre-intervention to post-intervention Activity / Variable Pre-intervention Clinical outcome collection (t1) Washout (t 2) Post-intervention Clinical outcome collection (t 3) Time (months) -12 0 6 Centre selection and activation (agreements, audit, standardisation) X Training of local faculty (train-the-trainer) x Simulation training implementation (workshop + checklist + debriefing) X Process measures (number of sessions, proportion of staff trained) X Primary outcome (failure of first instrument) X X Maternal secondary outcomes X X Neonatal secondary outcomes X X Educational measures (Likert scale, checklist performance) X SPIRIT Table. Outcome data are not collected during the washout period to minimise contamination, as varying proportions of clinicians are trained during this phase. Appendix 2. STROBE Checklist (for Observational Studies) STROBE Item Recommendation Location in Manuscript 1 Study design indicated in title/abstract Title; Abstract – Methods 2 Scientific background and rationale Abstract – Background; Introduction 3 Specific objectives Abstract – Objective 4 Study design Methods – Study Design 5 Setting, locations, dates Methods – Study Setting; Results (Current Study Status) 6 Participants and eligibility criteria Methods – Participants 7 Variables clearly defined Methods – Outcome Measures; Covariates 8 Data sources and measurement Methods – Data Collection and Management 9 Bias Methods – Study Design; Intervention (washout period) 10 Study size Methods – Sample Size Considerations 11 Quantitative variables Methods – Statistical Analysis 12 Statistical methods Methods – Statistical Analysis 13 Participants flow Multimedia Appendix 2 14 Descriptive data Planned (protocol) 15 Outcome data Planned (protocol) 16 Main results Not applicable (protocol) 17 Other analyses Methods – Secondary Analyses 18 Key results Not applicable (protocol) 19 Limitations Planned for final results paper 20 Interpretation Planned for final results paper 21 Generalisability Introduction; Study Setting 22 Funding Results (Current Study Status) Results: At the time of manuscript submission, ethical approval and funding were obtained (July 2024). Centre recruitment and site agreements are ongoing. Data collection is planned to begin in the fourth quarter of 2024 and is expected to be completed by mid-2026. Data analysis will commence thereafter, with results anticipated for publication in late 2026. Conclusions: This paper describes the protocol for a multicentre study designed to assess the effectiveness of a simulation-based training programme in vacuum-assisted vaginal birth. By providing robust evidence on its impact on operative vaginal birth practice and outcomes, the study aims to address important methodological shortcomings of previous research and to inform the development of standardised training strategies in this field.

  • Technical Approaches to Predicting Acute Deterioration in Pediatric Inpatients: Protocol for a Scoping Review

    Date Submitted: May 2, 2026
    Open Peer Review Period: May 3, 2026 - Jun 28, 2026

    Background: Early warning systems are widely used to detect acute clinical deterioration, which may be defined as a significant worsening in health over a few hours that may lead to adverse outcomes such as code blue activation, unplanned intensive care unit admission, or death. These systems rely on regular measurement of physiological parameters, such as heart rate and blood pressure, which are converted into warning scores using deterioration prediction algorithms (DPAs). A range of DPAs are currently in use, most commonly simple track-and-trigger tools or summative scoring systems. More complex machine learning approaches have been proposed that may improve prediction accuracy. However, heterogeneity in outcome definitions and reported model performance metrics hinders evidence synthesis needed to support deployment of proposed models in clinical contexts. Objective: This scoping review aims to identify the range of DPAs developed for use in pediatric inpatient early warning systems, as well as operational definitions of deterioration and reported performance metrics. Methods: The review will follow the Joanna Briggs Institute methodology for scoping reviews and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) reporting guidelines. The population of interest is hospitalized children. The concept under review is deterioration prediction algorithms, defined as decision-support tools that use routinely monitored physiological parameters to alert clinicians to worsening clinical status. The context will be inpatient ward settings, excluding emergency departments, neonatal units, and intensive care environments. Studies will be identified from searches on the MEDLINE (Ovid), Scopus, Web of Science, Cochrane, and ACM DL databases. Studies will be screened by two independent reviewers against the inclusion and exclusion criteria. A broad range of study types, including prospective and retrospective analyses, will be eligible for inclusion. Data on the choice of algorithmic approach, definition of deterioration, and reported performance metrics will be collated and analyzed. The results will be presented descriptively in tabular and narrative formats. Results: At the time of submission, the protocol has been registered and the search strategy finalized. A formal database search has been carried out in April 2026. Screening and data extraction are expected to occur over the following 6 months, after which the findings will be published. Conclusions: This protocol describes the planned scoping review of deterioration prediction algorithms for pediatric inpatient care. The completed review will summarize the types of algorithms evaluated, the outcomes used to define deterioration, and the performance metrics reported. These findings will support further evidence synthesis in this emerging field. Clinical Trial: Registered on Open Science Framework at https://osf.io/eg9cs(DOI: 10.17605/OSF.IO/EG9CS)

  • Background: In Australian residential aged care, infection prevention and control (IPC) lead nurses are a key part of the IPC program. IPC Leads are often the main IPC contact and provide support to staff to improve IPC and resident outcomes. To enhance their competence and self-efficacy, IPC Leads need to engage in ongoing role development. Connecting with others IPC Leads, learning together and sharing ideas and resources could also be beneficial. Communities of practice (CoPs) have been shown to improve self-efficacy and job satisfaction by fostering belonging, peer learning and problem-solving. Drawing on social learning theory, CoPs encourage learning with and from one another to explore and iteratively develop practice. This study draws on the CoP literature and builds on our previous pilot of a CoP for IPC lead nurses in one state of Australia, which found promising impacts on confidence and practice change. Objective: This study will evaluate CoPs for IPC Leads working in Australian residential aged care. Primarily the study will assess for change in IPC Leads’ self-efficacy. It will also explore job satisfaction, IPC practice improvement and assess the acceptability and feasibility of CoPs. Methods: A before-and-after study design using multi-methods. We will recruit IPC Leads from across Australia to participate in the CoPs. The CoPs will be implemented over 12 months, with online sessions held monthly for 30-60 minutes each. Baseline and 12-month follow-up surveys of IPC Leads’ self-efficacy and job satisfaction, and audits of IPC practice will be conducted. At 12-months follow-up, surveys and interviews with IPC Leads will be assess acceptability and feasibility of the CoPs and explore case examples of IPC Leads facilitating practice change. Researcher notes and costings data collected will be used to further evaluate the feasibility and fidelity of the CoPs. Results: This project was funded in October 2024 and commenced in February 2025. Recruitment of IPC Leads began in March 2026. The CoPs are expected to commence in June-July 2026. Data collection will commence in June 2026 and is expected to be completed by January 2028. Conclusions: Findings will create new research knowledge in the field of CoPs and knowledge translation in the aged care sector and will inform the sustainability and potential for future scale-up of this collaborative social learning approach. Clinical Trial: Not applicable

  • Background: Transcutaneous auricular vagus nerve stimulation (taVNS) is an emerging neuromodulation technique in rehabilitation research. While implanted vagus nerve stimulation is used clinically for epilepsy and treatment-resistant depression, its non-invasive form has mainly been explored in experimental settings, including physiotherapy and neuropsychiatry. Very few studies have investigated taVNS in speech-language pathology. However, given the vagus nerve's role in motor and sensory swallowing control, taVNS may offer a promising approach for dysphagia management - a frequent and severe complication in elderly stroke patients. Therefore, the development of an innovative protocol integrating taVNS appears pertinent in the context of swallowing rehabilitation. Objective: This protocol aims to evaluate the efficacy of taVNS combined with standard speech-language therapy for improving pharyngolaryngeal swallowing function and quality of life in elderly patients (≥70 years) with acute post-stroke dysphagia. Methods: This single-center, two-arm, randomized controlled clinical trial is conducted in a single-blind design. A total of 20 participants are expected to be enrolled. Eligible patients will be randomly allocated to receive either standard speech-language therapy combined with an inactive tVNS-E device, or standard speech-language therapy combined with non-invasive auricular vagus nerve stimulation via an active tVNS-E device. Both groups will undergo four rehabilitation sessions per week over three weeks. Clinical assessments (GUSS, SWAL-QoL, food trial) will be conducted at baseline T0 (inclusion) and at the end of the protocol at T3 (Week 3 – Day 4). Results: The study is currently in the participant recruitment phase. Recruitment began in April 2026. Baseline and post-test data collection is expected to continue until February 2028. Data analysis is planned for March 2028, and study results are expected to be published in April 2028. Conclusions: This will be the first randomized controlled trial evaluating taVNS for post-stroke dysphagia rehabilitation in patients aged ≥70 years. If effective, taVNS could provide a non-invasive adjunct to conventional speech-language therapy. Clinical Trial: ClinicalTrials.gov (NCT07428590)

  • Background: Cancer is a significant public health challenge in India, contributing to 8.3% of deaths and 5.0% of DALYs in 2016—nearly double its burden in 1990. Fragmented service delivery, limited specialist availability, late presentation, and significant financial hardship continue to hinder access to timely and effective cancer care, particularly in rural and underserved regions. National initiatives such as the NP-NCD and Ayushman Bharat have expanded diagnostic and treatment coverage; however, critical gaps remain in infrastructure, human resources, and quality of care. A comprehensive, system-level assessment is essential to inform evidence-based planning and strengthen cancer services nationwide. Objective: This study aims to evaluate the availability, readiness, and geographic distribution of cancer care services in India and to identify disparities across rural–urban settings and healthcare sectors. A secondary objective is to develop a framework to strengthen cancer service delivery across the continuum of care. Methods: A cross-sectional, descriptive study will be conducted across 32 States/UTs over three years. Using proportionate sampling, districts will be selected based on rural and urban population distribution. Nodal hospitals—preferably those hosting Hospital-Based Cancer Registries—will coordinate data collection from primary, secondary, and tertiary cancer care facilities. A structured electronic pro forma will capture data across six quality-of-care domains: equitable, effective, patient-centred, safe, efficient, and timely. Data will be entered through an online portal and monitored centrally. Descriptive statistics will summarise service availability, while Chi-square tests will assess differences across facility types, sectors, and geographic strata. Results: Ethical approval was obtained from the ICMR-NCDIR Institutional Ethics Committee (NCDIR/IEC/3058/2022); no individual patient data will be collected, all responses will be anonymised, and participation will be voluntary Conclusions: This situational analysis will generate critical evidence on India’s cancer care landscape, highlighting disparities and system gaps. Findings will support policymakers and programme managers in strengthening infrastructure, workforce deployment, and service delivery to advance equitable and comprehensive cancer care nationwide.

  • Background: Medical record review (MRR) is a common research method that uses information recorded in patient health records to answer health-related questions. MRRs help researchers learn about disease prevalence and practice patterns, treatment variation, outcomes, and healthcare quality and safety. It is relatively inexpensive and can be conducted efficiently. However, challenges such as missing data, inaccurate terminology, and inconsistent documentation are potential sources of bias, undermining the validity of MRRs. Prior MRR checklists are limited due to being outdated, incomplete, or not designed for newer approaches such as those involving electronic health records (EHRs). Objective: To develop expert-approved recommendations and a checklist for the conduct and reporting of MRRs addressing both traditional chart reviews and contemporary EHR-based research. Methods: We will conduct an expert consensus study using a modified Delphi approach following the ACCORD guideline for consensus methods in biomedicine. The process will be informed by a systematic review of the literature on the conduct, reporting, and quality assessment of MRR studies, registered on the Open Science Framework website (https://osf.io/9yj8r/overview). A multidisciplinary panel of 27 experts, primarily drawn from but not restricted to the Pediatric Emergency Research Canada (PERC) network and was selected purposefully to ensure diversity in expertise, background, and experience. Candidate checklist items identified through the literature review and an initial meeting will be evaluated over up to three rounds of anonymous online Delphi surveys using 5-point Likert scales. Items not reaching consensus (<75% approval) will be revised iteratively. A steering committee will oversee the process, and an in-person consensus meeting will be held to refine draft guidelines. Approval of the final version of the recommendations by at least 90% of the experts will be required. The final version will be tested with a broader group of patient partners, international researchers and stakeholders to ensure it is practical and useful. Based on institutional policies, this project was considered outside the mandate of the Research Ethics Board and therefore did not require ethics approval. Results: This project received financial support from the Canadian Institutes of Health Research (Planning and Dissemination Grant# 204652) in November 2025. The first three rounds of Delphi surveys were conducted in December 2025 to March 2026. The recommendations are expected to be completed in the Spring of 2026 and be externally evaluated in the summer of 2026. Conclusions: This project will lead to more rigorously designed MRR studies, thereby improving the quality of healthcare research to inform patient care.

  • Remote Monitoring for Rheumatoid Arthritis Flare during Drug Tapering: Protocol for a Prospective Observational Cohort Study

    Date Submitted: Apr 28, 2026
    Open Peer Review Period: Apr 29, 2026 - Jun 24, 2026

    Background: Rheumatoid arthritis (RA) disease activity during disease-modifying antirheumatic drug (DMARD) tapering is commonly monitored using in-person clinical assessment and the 28-joint Disease Activity Score with C-reactive protein (DAS28-CRP). Although effective, this approach is resource intensive and may be inconvenient for patients. Remote monitoring using patient-reported outcome measures and wearable sensors may offer a practical way to detect flare earlier and support safer tapering pathways. Prior pilot work suggests that accelerometery-derived physical activity, mobility, and sleep metrics are associated with RA disease activity and are acceptable to patients. Objective: This protocol aims to evaluate the feasibility and diagnostic accuracy of remote monitoring for detecting RA flare during DMARD tapering. The study will (1) continuously measure physical activity using wrist-worn accelerometers, (2) collect weekly Rheumatoid Arthritis Flare Questionnaire (RA-FQ) scores, (3) develop a joint modelling framework to estimate flare risk from longitudinal activity data, and (4) retrospectively assess prediction accuracy against patient- and clinician-defined flare onset. Methods: This is a prospective observational cohort study embedded within the ROADMAP DMARD tapering clinic at the Freeman Hospital, Newcastle upon Tyne, United Kingdom. Adults with clinician-confirmed RA in remission (DAS28-CRP <2.4) who are undergoing or about to start DMARD tapering and can walk independently will be recruited. The target sample size is 100 patients. Study visits are aligned with routine ROADMAP appointments and include baseline and week 12 assessments, with an optional 12-week extension (week 24) and ad hoc visits for suspected flare. Patients will wear wrist-worn Axivity AX6 devices continuously for 12 weeks (three devices worn sequentially for 28 days each), with an optional further 12 weeks in the extension phase. Weekly RA-FQ data will be collected via REDCap or paper questionnaires if needed. Clinical assessments include tender and swollen joint counts, patient and physician visual analogue scales, C-reactive protein, DAS28-CRP, and Health Assessment Questionnaire Disability Index scores. Flare status will be defined using clinician assessment supported by DAS28-CRP and/or swollen joint count criteria. A joint modelling framework combining longitudinal accelerometery-derived metrics and time-to-event analysis will generate daily flare-risk predictions. Model performance will be evaluated using area under the receiver operating characteristic curve, sensitivity, specificity, predictive values, and lead time to flare detection. Results: As of April 2026, 16 patients have been recruited. This protocol reports the study design, procedures, and planned analyses; outcome analyses will be reported after follow-up completion. Conclusions: This study will provide pilot evidence on the feasibility and accuracy of multimodal remote monitoring for RA flare detection during DMARD tapering in routine care. Findings will inform model refinement, external validation, and future larger multicentre studies evaluating clinical utility and service impact.

  • Background: Despite being a major burden in low- and middle-income countries in India, the understanding of cancer and its treatment remains limited. Adverse drug reactions (ADRs) from chemotherapy, polypharmacy, drug interactions and the cost of care also pose challenges for patient safety and health economics. Objective: This protocol describes the design of a prospective, observational, cross-sectional study that will evaluate chemotherapy drugs based on their usage, ADRs, and drug interactions, as well as undertake pharmacoeconomic analyses, including cost-effectiveness analysis, cost-utility analysis, and budget impact analysis to guide safe and cost-effective cancer treatment. Methods: The research will involve 67 adult cancer patients on chemotherapy in the oncology department of a tertiary care hospital in India for eight months. The Case Record Form will be used for data collection. Pharmacovigilance estimates will be done using standardised instruments (WHO-UMC scale, Naranjo algorithm, Hartwig and Siegel scale, Schumock and Thornton criteria). Economic analyses will include cost analysis, cost-effectiveness analysis (ICER), cost-utility analysis (ICUR) and budget impact analysis. Polypharmacy (use of >=5 drugs) and drug-drug interactions will also be assessed. Results: The study will confirm a high burden of ADRs, polypharmacy, and financial toxicity with chemotherapy. Results will demonstrate the link between prescription complexity, safety and cost. Conclusions: Linking pharmacovigilance with pharmacoeconomics will support rational prescribing, encourage generic and biosimilar uptake, and ultimately improve safety, affordability, and access to cancer treatment. Clinical Trial: CTRI/2025/10/096700 (Registered on: 31/10/2025)

  • Integrative Prevention at Work: Protocol for the Development of an Assessment Tool

    Date Submitted: Apr 27, 2026
    Open Peer Review Period: Apr 28, 2026 - Jun 23, 2026

    Background: In a changing world of work, integrative prevention at work represents a promising avenue for addressing contemporary health, safety and well-being issues. However, for organizations to deploy and benefit from this approach, developing an assessment tool for integrative prevention appears to be the first required step. No existing assessment tool can assess all its key characteristics on a unified scale, limiting the operationalization of this approach in organizations. Objective: The general objective of this project is to develop an assessment tool for integrative prevention at work intended for organizations in the health and social services sector. Specifically, this project aims to: 1) to generate items, rating scales and instructions; 2) to validate the content of the tool; 3) to pre-test the tool in organizational settings and 4) to evaluate its psychometric properties. Methods: A four-phase methodological study will be carried out for each research objective. The assessment tool will be developed and tested in the health and social services organizations in Quebec, Canada. Results: Phase 1 is complete: A total of 96 items were created and distributed relatively evenly across five subscales, each reflecting one attribute of integrative prevention at work. Phase 2 will be finalized by the end of 2026. Phases 3 and 4 will be completed by the end of 2028 to provide a validated tool to assess the key characteristics of integrative prevention at work. Conclusions: From an organizational perspective, this tool will provide health and social services organizations with a validated, context-adapted measure of integrative prevention at work, enabling baseline assessment, targeted improvements, and longitudinal monitoring, thereby strengthening prevention practices. From a research perspective, this project will deepen the understanding of integrative prevention at work through its empirical validation.

  • Outdoor Free Play in Children Aged 0–12 Years: Protocol for a Systematic Review of Intervention Effects and Implementation Characteristics

    Date Submitted: Apr 27, 2026
    Open Peer Review Period: Apr 28, 2026 - Jun 23, 2026

    Background: Outdoor free play is associated with benefits for children’s health, yet opportunities have declined and intervention approaches remain heterogeneous. A clearer understanding is needed of which interventions are effective and under what implementation conditions. Objective: This systematic review aims to synthesize interventions related to outdoor free play in children aged 0–12 years, evaluate their effects on child health and developmental outcomes, and characterize intervention components, delivery strategies, and implementation features.  Methods: We will search MEDLINE, Embase, CINAHL, Scopus, CENTRAL, and Web of Science. Eligible studies will use experimental or quasi-experimental designs to examine interventions related to outdoor free play, defined as child-directed play outdoors that is not structured by adults. Interventions will include but not be limited to modifications to environments, policies, supervision, or resources. The primary outcome will be any quantitative child health or developmental outcome. Studies must provide sufficient detail to identify core components, delivery format, target population, and setting. Two reviewers will independently screen studies, extract data, and assess risk of bias using Cochrane Risk of Bias 2 tool and ROBINS-I. Intervention characteristics and implementation factors will be synthesized descriptively using TIDieR and RE-AIM. Where appropriate, meta-analyses will be conducted using random-effects models, with subgroup analyses by age and setting, and sensitivity analyses restricted to studies at low risk of bias. Results: Funded in Decembre 2025, search strategy ran in April 2026 and title and abstracts screening started as of April 2026. Conclusions: This review will identify which outdoor free play interventions are effective and feasible. By clarifying key components and implementation features, it will support decisions on selecting, adapting, and scaling interventions within local contexts. Clinical Trial: PROSPERO no CRD420261376414; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261376414

  • Automated Digital Wellness Coaching for Working-Age Adults: Protocol for a Cluster Randomized Controlled Trial

    Date Submitted: Apr 28, 2026
    Open Peer Review Period: Apr 28, 2026 - Jun 23, 2026

    Background: Digital interventions provide a scalable, resource-saving approach to promote well-being and health and prevent lifestyle-related chronic health conditions, but their ability to engage and benefit diverse audiences remains a challenge. Objective: This study aims to evaluate a 6-month web-based wellness coaching program among working-age adults. The program is theory- and evidence-based, co-designed, and targets three behavioral domains (physical activity, diet, sleep) with an overarching focus on stress–recovery balance. Methods: The study follows a 2-arm parallel cluster randomized controlled design and lasts 12 months. Participants with age 18–65, proficiency in Finnish, and access to Internet were recruited from diverse worksites (n=13) in Central and Southwestern Finland. The sites were allocated 1:1 to intervention (coaching program) or waitlist control arm (general information on well-being). Data collection comprises fitness tests (handgrip strength, heart rate variability, body composition, waist circumference, BMI) and questionnaires conducted at months 0, 6, and 12, together with continuous monitoring of implementation costs, study uptake, dropout, and engagement (eg, visits to and time spent on the coaching platform). The primary outcome is the participant-level change in self-reported well-being (WHO-5 Well-Being Index) from baseline to 12 months. Secondary outcomes include changes in measures reflecting physical fitness, anthropometrics, lifestyle behaviors, health, and functional capacity. Further evaluation domains include health economic impact (eg, changes in well-being-, productivity-, and quality-adjusted life years), feasibility (study uptake, dropout, and engagement), and user experiences (acceptability, overall evaluation, and readiness to recommend the coaching program). Planned analyses will be conducted on the intention-to-treat principle and include linear mixed-effects models and health economic modelling. Results: The study received ethical approval in May 2025. Participant registration was open in September–October 2025, informed consents were collected in October–November 2025, and baseline assessments were conducted in October–December 2025. Consents were obtained from 294 and complete baseline data from 268 participants. Data collection will be completed within 2026, data analysis is planned for 2026–2027, and the dissemination of results will begin in 2027. The study is conducted as a part of the European Union’s Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) that has received funding from the EU4Health Programme 2021–2027. Conclusions: The study contributes to evidence on the potential of fully automated digital tools to enhance workforce well-being and save societal costs. Clinical Trial: ISRCTN Registry ISRCTN12097902 https://doi.org/10.1186/ISRCTN12097902 (date of registration: 06/08/2025)

  • Background: ADHD affects over 366 million adults and 139 million children worldwide, yet diagnosis remains fundamentally subjective, relying on clinical interviews, behavioral observations, and rating scales that yield inconsistent results across practitioners and settings. Artificial intelligence (AI), machine learning (ML), and deep learning (DL) offer a paradigm shift toward objective, data-driven diagnosis by detecting complex patterns across neuroimaging, electrophysiology, and digital biomarkers that elude conventional assessment. Although AI-based ADHD research has grown exponentially, no comprehensive synthesis examines the full spectrum of data modalities, validation practices, and clinical translation readiness. This gap limits our understanding of which approaches are most promising for real-world implementation. Objective: This scoping review will visually map the current evidence on the AI-based ADHD classification with respect to predictive accuracy, data forms, data features, generalizability, and interpretability of models. Methods: This scoping review will use the Joanna Briggs Institute (JBI) approach to scoping reviews and follow the Preferred Reporting Items of Systematic Reviews and Meta-Analyses Extension Scoping Reviews (PRISMA-ScR) guidelines. Five electronic databases such as IEEE Xplore, Scopus, PubMed, Web of Science, and ACM Digital Library will be systematically searched for peer-reviewed studies published between January 2019 and April 2026. Empirical studies in English involving the use of AI, ML, DL or explainable AI (XAI) to diagnose ADHD with a sample size of greater than 100 individuals, and a control group (typically developing or healthy group) will be included. Two independent reviewers will screen the titles, abstracts and full texts, and any conflicts will either be resolved through discussion or through arbitration. A standardized template of Excel will be used to extract data that will include the following: bibliographic data, data modalities, data models, data validation approaches, performance metrics, and explainability approaches. Thematic and narrative analysis will be used to synthesize findings in four research questions that will address model performance, data modality contributions, data characteristics, and interpretability methods. Results: The results will be included in the scoping review, which began in December 2025. Analysis and screening is in progress, with the scoping review expected to be completed and submitted for publication in June 2026. Conclusions: This scoping review will provide the first comprehensive synthesis of AI-, ML-, and DL-based ADHD diagnostic classification studies, mapping the evidence across data modalities, validation practices, interpretability methods, and clinical translation readiness. Findings will inform future methodological standards and support the translation of AI-based diagnostic tools into clinical practice.

  • Background: Preschool children suffering from oral diseases have high levels of visible plaque is found on tooth surfaces signify the importance of oral hygiene maintenance for good oral health. Literature indicates that preschool children, specifically those aged 3 to 6 years, lack the fine motor skills and cognitive coordination required to perform effective plaque removal independently. Supervised Toothbrushing (STB), have demonstrated superior efficacy in reducing plaque scores and improving health. Older children will perform the task independently, But still they need assistance whereas younger children may need more support and supervision during brushing. Every month, children will participate in supervised toothbrushing programs where they brush their teeth at school using fluoridated toothpaste while being watched over by staff and peers. Despite the availability of various school health initiatives, the implementation of supervised brushing programmes in preschool settings is often limited. This paper presents the study protocol for newly introduced BrushYen Supervised Tooth Brushing Programme aims to promote ideal brushing technique, enhance children's motivation and establish consistent oral hygiene habits. However, there is limited evidence regarding its effectiveness among preschool children. Objective: To evaluate the reduction in plaque scores among preschool children at 1, 3, and 6 months following the implementation of the "Brushyen" program. And to assess the improvement in gingival health status at the same intervals. Another objective of the study is to determine the improvement in toothbrushing skills (dexterity) and parental awareness regarding oral hygiene. Methods: This study is a Quasi-experimental study. A total of 120 preschoolers studying in montessari of The Yenepoya school. The Monthly supervised toothbrushing sessions will be conducted post-lunch, where the BrushYen Champions will assist the teachers in monitoring the preschoolers. Clinical parameters will be recorded using the identical set of indices Visible Plaque Index, Modified Gingival Index, and Modified OHI-S to allow for a direct statistical comparison against baseline values, Participants will be followed up at 1, 3, and 6 months. Results: Enrollment started in June 2026. It is estimated that the enrollment period will be 12 months. Data collection is planned to be completed in 2027. Conclusions: The BrushYen Supervised Tooth Brushing Programme aims to promote ideal brushing technique, enhance children's motivation and establish consistent oral hygiene habits. However, there is limited evidence regarding its effectiveness among preschool children Clinical Trial: Trial Acknowledgement Number is: CTRI/2026/03/107144

  • Background: Health care professional students represent as important target group for tobacco control interventions, as the behaviour established during their training years may influence both their future personal health practice and also their role in cessation counselling to patients. In recent years, mobile health (mHealth) has emerged as promising tool in tobacco cessation by providing accessible, personalized support, progress tracking and real time interventions. However, there is limited evidence on the specific design, personalized support. The Yenquit Application was developed based on 5As and 5Rs to address this gap by integrating user engagement feature aim to facilitate tobacco cessation. Objective: The objective of this study is to develop the YenQuit mobile/web-based application and aims to evaluate its features, effectiveness in promoting smoking cessation, and user engagement and experience among healthcare professional students. Methods: This study is a cross-sectional study. A total of 97 health care professional students that meet the inclusion criteria will have access to application, where they will fill the baseline questionnaire followed by Fagerström Test for Nicotine Dependence (FTND), Usage of application is monitored and end of 30 days of on boarding, the participants will fill the feedback on the effectiveness of the application. Results: : Enrollment started in March 2026. It is estimated that the enrollment period will be 12 months. Data collection is planned to be completed in 2027 Conclusions: The Yenquit mobile application is been developed as a user -friendly, evidence-based digital tool to support smoking cessation among health care professional students. By integrating behavioral counselling approach such as the 5As and 5Rs models, the application has the potential to enhance accessibility to cessation support in academic health settings. Further evaluation will provide insights into its effectiveness, user engagement, and acceptability as a mobile-based cessation intervention Clinical Trial: Trial Acknowledgement Number is: REF/2026/03/127126

  • Background: Knee osteoarthritis is a prevalent chronic condition associated with pain, functional limitations, and reduced quality of life. Exercise is the cornerstone of nonpharmacological management; however, long-term adherence to exercise programs remains challenging. Telerehabilitation has emerged as a promising strategy to improve access to supervised exercise, yet evidence comparing synchronous and asynchronous delivery formats, particularly in developing countries, is limited. This study protocol describes a randomized clinical trial designed to compare the effects of synchronous and asynchronous telerehabilitation exercise programs on pain, physical function, quality of life, and exercise adherence in individuals with knee osteoarthritis. Objective: Therefore, this study protocol describes a randomized clinical trial designed to evaluate the effects of two telerehabilitation exercise programs—synchronous (online) and asynchronous—on pain, functional capacity, and quality of life in individuals with knee osteoarthritis over a six-week intervention period. Methods: This single-center randomized clinical trial will include individuals aged 40–75 years with clinical and/or radiographic knee osteoarthritis. Participants will be randomly allocated to a synchronous or asynchronous telerehabilitation exercise program delivered over six weeks. Both groups will follow an identical, structured exercise protocol, differing only in delivery mode. Outcomes will be assessed at baseline and post-intervention. The primary outcome is pain and physical function. Secondary outcomes include quality of life, functional performance, and exercise adherence. The study protocol was adjusted following a preliminary feasibility study to optimize intervention delivery and monitoring procedures. Results: This study did not receive specific funding. The authors received individual scholarships and research support from CAPES and FUNDECT. Data collection began in August 2024, and by October 2025, a total of 30 participants had been recruited. Data analysis is currently ongoing. Manuscript preparation is expected to begin in May 2026, with submission planned for December 2026. Conclusions: This trial will provide evidence regarding the feasibility, adherence, and potential effectiveness of different telerehabilitation delivery formats for individuals with knee osteoarthritis. Findings may inform the development of accessible, low-cost rehabilitation strategies in settings with limited access to in-person care. Clinical Trial: Brazilian Registry of Clinical Trials (REBEC): RBR-3kzr42p; https://ensaiosclinicos.gov.br/rg/RBR-3kzr42p

  • ADHD Pharmacotherapy in the Context of Coexisting Eating Disorders: A Scoping Review Protocol

    Date Submitted: Apr 17, 2026
    Open Peer Review Period: Apr 21, 2026 - Jun 16, 2026

    Background: Eating disorders (EDs) and attention-deficit/hyperactivity disorder (ADHD) co-occur at rates substantially exceeding chance, potentially due to shared neurodevelopmental, genetic, and reward-processing mechanisms. Despite growing clinical recognition of this overlap, no comprehensive synthesis of the effects of ADHD pharmacotherapy on ED outcomes in individuals with co-occurring ADHD and EDs currently exists. Clinicians prescribing ADHD medications to this population must balance potential risks, including appetite suppression, weight loss, and misuse, against possible benefits, including improved impulse control, improved engagement in ED treatment, and reduced binge-eating frequency, all in the absence of astructured evidence base to draw upon. Objective: This scoping review aims to: (1) map existing evidence on the effects of ADHD pharmacotherapy on ED symptom outcomes in individuals with co-occurring ADHD and EDs; (2) characterise the safety and tolerability profile of ADHD medications in this population; (3) describe the range of study designs, populations, medication types, and outcome measures re- ported in the literature; and (4) identify key methodological gaps to inform future research priorities. Methods: The review will follow the PRISMA Extension for Scoping Reviews methodology. Eligible studies will include individuals with a formal diagnosis of ADHD or clinically significant ADHD symptoms, alongside a diagnosed ED or clinically significant ED pathology, across all ED diagnoses and age groups. Any pharmacological agent approved or used off-label for ADHD, including stimulants and non-stimulants, will be eligible as the primary intervention. All study designs will be included, from randomised controlled trials to case reports, consistent with the anticipated sparsity of controlled trial data in this population. Seven electronic databases will be searched (MEDLINE, Embase, PsycINFO, PubMed, CENTRAL, Web of Science, SCOPUS), alongside trial registries and manual searches. Title/abstract and full-text screening will be conducted independently by two reviewers, with discrepancies resolved by a senior reviewer. Findings will be synthesised narratively, structured by population group, medication class, and outcome domain. Results: Ethics & Dissemination Ethical approval is not required as this review involves secondary analysis of publicly available data. Findings will be disseminated via peer-reviewed publication and are intended to inform prescribing practice, highlight evidence gaps, and provide a foundation for future controlled research at the intersection of ADHD and EDs. Conclusions: Ethics & Dissemination: Ethical approval is not required as this review involves secondary analysis of publicly available data. Findings will be disseminated via peer-reviewed publication and are intended to inform prescribing practice, highlight evidence gaps, and provide a foundation for future controlled research at the intersection of ADHD and EDs.

  • Background: Workforce aging is accelerating, particularly among women aged 50 and over. In the healthcare sector, older nurses face increased exposure to occupational injuries, including musculoskeletal disorders and burnout, which may result in work disability. Following an occupational injury, nurses must navigate complex decisions involving return to work or retirement. These decisions occur within interacting personal, organizational, healthcare, and compensation systems. The determinants of these post-injury employment trajectories remain insufficiently documented, which limits the development of targeted interventions to support reintegration in employment or retirement transitions. Objective: This study aims to identify the factors that influence employment trajectories of nurses aged 50 and over following an occupational injury. Methods: This study uses a two-stage qualitative design. Stage 1 consists of a life‑story study based on semi‑structured interviews with approximately 20 nurses aged 50 and over who have experienced an occupational injury. Interviews will explore factors related to the worker, the work environment, the healthcare system, and the compensation system. Data will be analyzed using thematic analysis. This stage will generate preliminary recommendations to support return to work or transition to retirement. Stage 2 consists of a nominal group process to validate and refine these recommendations. Four nominal groups will be formed, each including four participants representing nurses, healthcare professionals, employer representatives, and insurer representatives. Participants will assess the relevance, clarity, and completeness of the recommendations. Data will be analyzed using descriptive statistics and qualitative content analysis. Results: Participant recruitment and data collection began in September 2025 and are expected to continue until October 2026. Conclusions: This study will identify key facilitators and barriers shaping post-injury employment trajectories of nurses aged 50 and over. The findings will inform actionable recommendations to support sustainable return to work or structured transition to retirement in this growing segment of the healthcare workforce.

  • Background: Despite significant advancements in HIV care, all components of the care continuum from diagnosis to antiretroviral treatment (ART) uptake and sustained virologic suppression (VS) are worse for adolescents and young adults with HIV (AHIV) (ages 12-30). ART adherence remains elusive for ≈60% of AHIV, impeding the goal of the Ending the HIV Epidemic in the United States Initiative (EHE). Even when AHIV are suppressed, medication fatigue and other factors threaten sustained virologic control. Long-acting injectable ART (LAI-ART) has the potential to improve the care continuum for AHIV. Objective: The Strategies to Achieve Viral Suppression for Youth with HIV Study (SAVVY) aims to evaluate the impact and implementation of an informed choice-counseling intervention on ART options, including its impact on intervention acceptability, participants’ ART selection and later facilitated access, and the clinical outcome of VS rates among AHIV. We also aim to assess determinants influencing LAI-ART implementation outcomes, guided by the Consolidated Framework for Implementation Research. Methods: SAVVY is a preference-guided, observational, type-1 effectiveness implementation study, investigating the efficacy of precision engagement approaches to patient counselling on options for ART that are approved for patients with viral load (VL) <50 copies/mL. Patients eligible for enrollment are AHIV (ages 12-30) engaged in clinical care and prescribed ART (N=288). All participants undergo CHOICE counseling (CC), where they are presented with and decide on their preferred ART options (oral ART [oART] or LAI-ART) using a computer-assisted precision engagement tool (HIV-ASSIST). The SAVVY LAI-ART Access Team facilitates [EW1.1][EO1.2]access and logistics for those who qualify for and choose LAI-ART. At entry, enrollees are divided into two cohorts: those with HIV RNA PCR VL ≥50 copies/mL (Cohort 1a) and those with VL <50 copies/mL (Cohort 1b). Cohort 1a participants are informed of VL requirements to qualify for LAI-ART, receive supportive messages and biweekly VL measurements [EW2.1][EW2.2]for three months, and are re-offered CC upon achieving VL<50 copies/mL. Enrollees with persistent VL ≥50 copies/mL at 3 months continue standard oART with the option of referral for LAI-ART once VL is <50 copies/mL. Cohort 1b participants undergo CC and can proceed to LAI-ART or maintain oART. The primary outcome is VS (VL<20 copies/mL), comparing the oART and LAI-ART groups. SAVVY is JHU IRB-approved and registered on clinicaltrials.gov (NCT06886971). The first participant was enrolled in November 2024 with full accrual anticipated in 36 months. Results: n/a Conclusions: SAVVY represents a pragmatic, feasible implementation strategy towards informed, personalized ART decision-making among AHIV, which could expand access to beneficial novel technologies. It aims to use the proven approach of youth-centered care, where treatment choices are self-driven by youth, to improve LAI-ART uptake and persistence[EW3.1], increase VS, and improve overall outcomes for AHIV.

  • Background: Family planning program has been globally shown to reduce maternal mortality by reducing both total and high-risk pregnancies. Despite the national implementation of this program since the 1970s, Indonesia still faces many challenges in achieving family planning goals. Low modern contraceptive prevalence rate (mCPR) remains a problem that impacts public health, population growth, economy, and welfare issues. It should be tackled, especially in rural areas, with multifactorial causes and diverse needs. Various programs have been developed globally to overcome this problem; however, each region has different characteristics and demands that should be understood. Objective: This study aims to develop a theory of change by understanding rural women’s needs and actively collaborating with multiple participant groups to increase modern contraceptive uptake. The theory of change will also be informed by the views of four distinct stakeholders who is responsible for providing contraceptive services (i.e. policy makers at regency and provincial level) in order to make informed recommendations. Methods: This feminist qualitative study embedding participatory action research principles adapts the first three steps of the six essential steps for quality intervention development. The target location is West Sumba Regency, one of Indonesia’s 100 lowest mCPR regencies and located in East Nusa Tenggara, which has the highest total fertility rate in Indonesia. Consisting of two rounds of data collection, this study includes different participant groups (i.e. rural women and men, mothers-in-law, religious figures, cultural leaders, midwives, family planning educators, and policymakers) with different strategies. To ensure data saturation and trustworthiness, we aim to recruit up to 45 participants through purposeful sampling, selecting participants based on the criteria for each group. The data collection methods are focus groups and semi-structured interviews. We will analyze the data using reflexive thematic analysis. Results: The theory of change development focuses on women’s voices and incorporates various perspectives from rural communities, including the service providers and policymakers. Ethics approval has been obtained by the College of Medical, Veterinary, and Life Sciences (MVLS) Research Ethics Committee, University of Glasgow, UK, and the Public Health Faculty, University of Nusa Cendana, Indonesia. We anticipate that we will complete all data collections and analysis by December 2026. Conclusions: The ultimate goal of this study is to develop a theory of change to create a meaningful change in contraceptive services in rural areas. This study will contribute to encourage rural communities to collaborate and empower rural women to overcome their reproductive health problems. By understanding the diverse contexts and specific needs of the rural population, the results will be essential to transforming family planning programs. In doing so, it will significantly enhance women’s reproductive health while also addressing and reducing health inequalities in rural areas.

  • Background: The relationship between female physical performance and menstrual cycle (MC) phases is widely discussed in applied sports science and clinical kinesiology. However, current evidence remains inconsistent, particularly regarding muscle strength and biomechanical risk factors for injury. Objective: This study aims to examine the relationship between MC phases and lower limb injury risk factors, with a particular focus on the hamstrings-to-quadriceps strength ratio (H/Q ratio). Methods: Following an initial session, participants will monitor their MC over 3 months using a mobile application, urinary ovulation tests, and self-reported symptoms, while also recording perceived readiness for physical activity. Each participant will then complete two laboratory assessments: the early follicular phase (days 1–3 of menstrual bleeding) and the peri-ovulatory phase. Testing will include isokinetic strength assessment, evaluation of muscle–tendon mechanical properties, and body composition analysis. Results: Recruitment will begin in June 2026. A total of 32 participants will be enrolled in two waves (June–July 2026 and June–July 2027). Preliminary results are expected by 06/2028. Conclusions: This study may improve understanding of MC–related changes in neuromuscular function and support individualized, non-invasive approaches to training and injury prevention in women. Associating objectively estimated MC phases with a mobile application, urinary ovulation tests and subjective perceptions of performance will provide insights into the agreement between perceived and physiological indicators of performance readiness. Clinical Trial: NCT07462286

  • Background: Asymptomatic bacteriuria (ASB) has been associated with preterm birth and pyelonephritis, and until recently, screening for ASB was recommended for all women in first trimester of pregnancy. Recent divergence between NICE guidelines (which do not recommend routine screening) and NHS initiatives such as the Saving Babies’ Lives Care Bundle (which recommends screening in high-risk women) may have led to inconsistencies in UK clinical practice. Objective: To describe the protocol for a national multicentre study evaluating variation in ASB screening practices across UK maternity units and examining associated maternal and neonatal outcomes. Methods: The TU(L)IPS study is a national, multicentre observational study conducted through the UK Audit and Research Collaborative in Obstetrics and Gynaecology (UKARCOG) network. The study comprises two components: (1) a structured survey of UK maternity units to characterise local ASB screening guidelines and practices, and (2) a retrospective cohort study using routinely collected clinical data to assess adherence to local and national guidance and to describe maternal and neonatal outcomes. Participating sites contribute data via a standardised REDCap-based data collection platform using predefined variables and harmonised outcome definitions. Analyses will be descriptive, including frequencies and proportions, with comparisons stratified by screening status, urine culture result categories, and preterm birth risk groups. Results: The study was launched nationally in January 2025. Recruitment closed with 28 NHS Trusts participating across the United Kingdom. Stage 1 data collection was completed in December 2025. Stage 2 data collection is scheduled to conclude in March 2026, with the database lock planned for March 2026. Data cleaning and analysis will commence following the database lock. The anticipated study completion date is May 2026. Conclusions: This study will provide a comprehensive national evaluation of variation in ASB screening practices and associated outcomes in pregnancy. By using a standardised, protocolised approach across multiple sites, the TU(L)IPS study aims to generate contemporary evidence to inform clinical practice and national policy.

  • Background: Renal fibrosis is the final common pathway of chronic kidney disease progression and a critical histological predictor of renal function decline and allograft failure. Routine clinical monitoring with estimated glomerular filtration rate (eGFR) and albuminuria is insensitive to the development of fibrosis. Renal biopsy is invasive, which limits repeated assessment and suffers from sampling bias. Consequently, non-invasive imaging biomarkers that can accurately quantify fibrosis, monitor disease progression, and predict outcomes are highly desirable. Multiparametric magnetic resonance imaging (mpMRI) offers extensive characterization of renal structural and functional properties. Previous work has indicated that MRI measures are associated with fibrosis development and with declining renal function. However, there remains a sparsity of longitudinal data and comprehensive validation of MRI measures against histology and measured glomerular filtration rate (mGFR). Objective: Our ongoing longitudinal study aims to validate mpMRI against reference standard kidney biopsy in kidney transplant recipients (KTR) and to compare the time-dependent trajectories of imaging and functional markers across living kidney donors (LKD), KTR and healthy control (HC) cohorts to assess their prognostic value for mGFR decline. Methods: Participants: 32 living kidney donors (LKD), 32 KTR, and 32 healthy controls (HC). Inclusion criteria: LKD and KTR who have been approved for transplant. HC must show no evidence of renal disease and have normal blood pressure. Exclusion criteria: Contraindications to MRI or severe claustrophobia. Time points: Baseline investigations prior to transplant surgery, with follow-up assessments at 3-, 12-, and 24-months post-transplant. Data collection: mpMRI is performed at 3T. The MRI protocol includes structural T1-weighted and T2-weighted imaging, T1 mapping, T2 mapping, T2* mapping, DWI, pseudo-continuous ASL, non-contrast-enhanced angiography, and phase-contrast measurement of renal artery flow. Glomerular filtration rate will be measured by [99mTc]Tc-DTPA clearance. A baseline allograft biopsy is performed in all KTR during the transplantation surgery. Subsequent protocol biopsies are planned at 3, 12, and 24 months in KTR. Extent of fibrosis is quantified using quantitative stereology. Primary outcome: Longitudinal association between quantitative MRI measures and histologically determined renal fibrosis. Secondary outcomes: Longitudinal divergence of MRI and functional markers across cohorts; diagnostic performance for fibrosis; and predictive value for mGFR decline in KTR and LKD. Linear mixed models will be used to study longitudinal associations. Receiver operating characteristic curve analysis will assess diagnostic performance. Results: Recruitment for the MPRENAL study commenced in November 2024. As of March 2026, enrolment is ongoing with 42 participants recruited. Full data analysis and results are projected for December 2029. Conclusions: Successful completion of this study is expected to provide robust histological validation of mpMRI and establish its utility as a non-invasive tool for monitoring renal health. Clinical Trial: ClinicalTrials.gov NCT06210555; https://clinicaltrials.gov/ct2/show/NCT06210555